Stephen Nicholls
#106,021
Most Influential Person Now
Australian cardiologist
Stephen Nicholls's AcademicInfluence.com Rankings
Stephen Nichollsmedical Degrees
Medical
#1344
World Rank
#1671
Historical Rank
Cardiology
#99
World Rank
#101
Historical Rank
Stephen Nichollsphilosophy Degrees
Philosophy
#4456
World Rank
#6972
Historical Rank
Logic
#1903
World Rank
#2771
Historical Rank
Download Badge
Medical Philosophy
Stephen Nicholls's Degrees
- Bachelors Medicine University of Melbourne
Why Is Stephen Nicholls Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stephen J. Nicholls FRACP, FACC, FESC, FAHA, FAHMS, is an Australian cardiologist. He was appointed to the position of director of MonashHeart, Monash Health and professor of cardiology, Monash University in October 2018. He is the inaugural clinical director of the Victorian Heart Hospital. He is also the inaugural director of Monash University’s Victorian Heart Institute, an organisation dedicated to creating the cardiovascular health solutions of the future.
Stephen Nicholls's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. (2006) (1952)
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. (2020) (1835)
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel (2017) (1817)
- Effects of dalcetrapib in patients with a recent acute coronary syndrome. (2012) (1782)
- Antiinflammatory Properties of HDL (2004) (1249)
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. (2007) (1188)
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction. (2021) (1081)
- Low-density lipoproteins cause atherosclerotic cardiovascular disease (2018) (936)
- Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. (2008) (836)
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (801)
- Effect of torcetrapib on the progression of coronary atherosclerosis. (2007) (773)
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. (2016) (765)
- Effect of two intensive statin regimens on progression of coronary disease. (2011) (744)
- Myeloperoxidase and cardiovascular disease. (2005) (719)
- Protein carbamylation links inflammation, smoking, uremia and atherogenesis (2007) (611)
- Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. (2007) (573)
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020) (541)
- Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. (2008) (522)
- Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular Disease (2017) (462)
- Impact of statins on serial coronary calcification during atheroma progression and regression. (2015) (443)
- Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. (2011) (418)
- Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. (2008) (413)
- Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. (2010) (397)
- Effect of ACAT inhibition on the progression of coronary atherosclerosis. (2006) (387)
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease (2019) (356)
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. (2020) (331)
- Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. (2008) (322)
- The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. (2014) (299)
- Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel (2015) (299)
- Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits (2005) (298)
- Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. (2014) (266)
- Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER). (2010) (234)
- Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. (2006) (221)
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk (2017) (216)
- Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis: Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation) (2008) (215)
- Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database (2010) (211)
- Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? (2012) (195)
- Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. (2006) (191)
- Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden (2008) (185)
- Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial. (2011) (170)
- Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel (2015) (167)
- Mendelian Randomization Study of ACLY and Cardiovascular Disease (2019) (166)
- Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. (2013) (164)
- Formation of dysfunctional high-density lipoprotein by myeloperoxidase. (2005) (164)
- An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). (2010) (162)
- Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. (2011) (153)
- Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. (2006) (151)
- Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits (2005) (151)
- Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) Trial (2006) (151)
- Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial (2018) (150)
- Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. (2012) (146)
- Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. (2006) (146)
- Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. (2010) (144)
- Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. (2014) (143)
- The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. (2010) (139)
- Myeloperoxidase, modified lipoproteins, and atherogenesis Published, JLR Papers in Press, December 16, 2008. (2009) (135)
- Coronary artery calcification and changes in atheroma burden in response to established medical therapies. (2007) (134)
- Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. (2020) (133)
- Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials. (2007) (129)
- Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial. (2013) (121)
- Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease. (2019) (115)
- Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. (2015) (115)
- -Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials (2007) (113)
- Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial. (2014) (113)
- C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy (2013) (109)
- Effect of Serial Infusions of CER-001, a Pre-&bgr; High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial (2018) (108)
- A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial). (2013) (106)
- Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events (2016) (105)
- Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruct (2011) (103)
- Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial (2018) (101)
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. (2020) (94)
- Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. (2013) (94)
- Intravascular imaging of vulnerable coronary plaque: current and future concepts (2011) (93)
- Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. (2009) (92)
- Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial (2016) (92)
- Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease. (2011) (92)
- Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction (2007) (91)
- Peripheral arterial disease and progression of coronary atherosclerosis. (2010) (90)
- Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER. (2016) (90)
- Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. (2013) (89)
- ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies (2012) (87)
- Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease (2018) (85)
- Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. (2008) (84)
- BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection (2021) (83)
- Rate of progression of coronary atherosclerotic plaque in women. (2007) (83)
- Effect of Evolocumab on Coronary Plaque Composition. (2018) (81)
- Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. (2020) (79)
- Advances in lipid-lowering therapy through gene-silencing technologies (2018) (78)
- Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study. (2014) (77)
- Optimizing outcomes during left main percutaneous coronary intervention with intravascular ultrasound and fractional flow reserve: the current state of evidence. (2012) (76)
- Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. (2020) (76)
- A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia. (2016) (76)
- Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy (2010) (74)
- Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. (2015) (74)
- Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. (2009) (71)
- Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). (2006) (70)
- Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial (2020) (70)
- Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life (2018) (68)
- Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis. (2014) (68)
- Factors underlying regression of coronary atheroma with potent statin therapy. (2013) (67)
- Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial (2017) (65)
- Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial (2019) (63)
- Biomarkers of inflammation and oxidative stress in atherosclerosis. (2010) (62)
- Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance. (2020) (61)
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. (2021) (61)
- Atheroma Progression in Hyporesponders to Statin Therapy (2015) (61)
- Intravascular ultrasound in cardiovascular medicine. (2006) (61)
- Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial. (2013) (61)
- Redox biomarkers in cardiovascular medicine. (2015) (60)
- Early life exposure to Chinese famine modifies the association between hypertension and cardiovascular disease (2018) (60)
- Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy: Randomized, Placebo-Controlled Study (FIRST) (2014) (58)
- The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. (2011) (58)
- Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement. (2020) (58)
- Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. (2022) (57)
- ATVB in Focus Redox Mechanisms in Blood Vessels (2005) (57)
- A Prospective, Randomized Trial of Single-Drug Versus Dual-Drug Immunosuppression in Heart Transplantation: The Tacrolimus in Combination, Tacrolimus Alone Compared (TICTAC) Trial (2011) (56)
- High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN (2014) (56)
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (2018) (55)
- Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV). (2016) (55)
- Coronary arterial calcification: A review of mechanisms, promoters and imaging. (2018) (54)
- Biomarkers: Application of intravascular ultrasound in anti-atherosclerotic drug development (2006) (53)
- Myocardial Infarction Associates With a Distinct Pericoronary Adipose Tissue Radiomic Phenotype: A Prospective Case-Control Study. (2020) (52)
- Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial (2012) (51)
- Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN. (2013) (51)
- Sharing Data from Cardiovascular Clinical Trials--A Proposal. (2016) (50)
- Antiatherosclerotic Effects of Long-Term Maximally Intensive Statin Therapy After Acute Coronary Syndrome: Insights From Study of Coronary Atheroma by Intravascular Ultrasound Effect of Rosuvastatin Versus Atorvastatin (2014) (49)
- Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes (2018) (49)
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease (2017) (48)
- Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound. (2014) (47)
- Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. (2017) (47)
- Inflammation and Neovascularization Intertwined in Atherosclerosis: Imaging of Structural and Molecular Imaging Targets (2014) (46)
- The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol. (2004) (46)
- Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial (2015) (45)
- Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain. (2011) (45)
- Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial. (2006) (45)
- High-density lipoproteins as therapeutic targets (2005) (45)
- Near-Infrared Spectroscopy Enhances Intravascular Ultrasound Assessment of Vulnerable Coronary Plaque: A Combined Pathological and In Vivo Study (2015) (45)
- Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events. (2013) (44)
- Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options (2019) (44)
- Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis (2016) (44)
- Coronary atherosclerosis can regress with very intensive statin therapy. (2006) (44)
- Exploring coronary atherosclerosis with intravascular imaging. (2013) (44)
- Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin versus AtorvastatiN) (2011) (44)
- Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. (2019) (43)
- Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound. (2017) (43)
- Visit-to-Visit Blood Pressure Variability, Coronary Atheroma Progression, and Clinical Outcomes. (2019) (43)
- The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs (2016) (42)
- Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease (2019) (42)
- Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy. (2014) (42)
- Coronary β2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. (2012) (41)
- Cholesterol crystals associate with coronary plaque vulnerability in vivo. (2015) (41)
- Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery Disease (2016) (41)
- Medical and lifestyle management of peripheral arterial disease. (2018) (40)
- Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia. (2020) (40)
- Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials (2013) (40)
- Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial. (2020) (40)
- Hypertriglyceridemia and Cardiovascular Diseases: Revisited (2016) (40)
- ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study (2018) (39)
- Is niacin ineffective? Or did AIM-HIGH miss its target? (2012) (39)
- Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial. (2021) (39)
- Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels. (2015) (38)
- Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment–Elevation Myocardial Infarction (2016) (38)
- The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications (2018) (38)
- Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial. (2013) (37)
- Ultrathin monolithic 3D printed optical coherence tomography endoscopy for preclinical and clinical use (2020) (37)
- Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden. (2017) (36)
- Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. (2019) (36)
- The role of myeloperoxidase in the pathogenesis of coronary artery disease. (2004) (36)
- HDL and cardiovascular disease. (2019) (36)
- High-risk coronary atheroma: the interplay between ischemia, plaque burden, and disease progression. (2014) (35)
- Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials. (2009) (35)
- Optical coherence tomography in coronary atherosclerosis assessment and intervention (2022) (34)
- Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial. (2006) (34)
- Frequency-domain optical coherence tomographic analysis of plaque microstructures at nonculprit narrowings in patients receiving potent statin therapy. (2014) (34)
- Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis. (2019) (34)
- Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. (2010) (34)
- Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. (2017) (33)
- Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study. (2021) (31)
- The Impact of Cardiac Rehabilitation and Secondary Prevention Programs on 12-Month Clinical Outcomes: A Linked Data Analysis. (2020) (31)
- Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients. (2016) (31)
- Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. (2006) (31)
- Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus (2013) (30)
- Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study (2021) (30)
- Subclinical Myocardial Necrosis and Cardiovascular Risk in Stable Patients Undergoing Elective Cardiac Evaluation (2010) (30)
- Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial. (2017) (30)
- Managing Dyslipidemia in Type 2 Diabetes. (2017) (29)
- Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer. (1996) (29)
- Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study. (2006) (29)
- The Effect of Bromodomain and Extra-Terminal Inhibitor Apabetalone on Attenuated Coronary Atherosclerotic Plaque: Insights from the ASSURE Trial (2018) (28)
- Comparison of coronary atherosclerotic volume in patients with glomerular filtration rates < or = 60 versus > 60 ml/min/1.73 m(2): a meta-analysis of intravascular ultrasound studies. (2007) (28)
- Dynamic Self-Referencing Approach to Whispering Gallery Mode Biosensing and Its Application to Measurement within Undiluted Serum. (2016) (28)
- Heart failure after conventional metal-on-metal hip replacements (2016) (27)
- Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International Collaboration (2017) (26)
- Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography. (2019) (26)
- Examining adherence to activity monitoring devices to improve physical activity in adults with cardiovascular disease: A systematic review (2018) (26)
- Optimization of whispering gallery resonator design for biosensing applications. (2015) (26)
- Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial. (2020) (26)
- The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights (2012) (26)
- Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. (2020) (25)
- Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case. (2015) (25)
- Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ) (2020) (25)
- ETC-216 for coronary artery disease (2011) (25)
- Cellular Therapy for Heart Failure (2016) (24)
- Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database. (2017) (24)
- High-density lipoproteins: an emerging target in the prevention of cardiovascular disease (2006) (24)
- Translating Evidence of HDL and Plaque Regression. (2018) (24)
- Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques. (2014) (23)
- Pericoronary adipose tissue computed tomography attenuation distinguishes different stages of coronary artery disease: a cross-sectional study. (2020) (23)
- Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events. (2016) (23)
- Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease. (2015) (23)
- Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease. (2019) (23)
- Quantification of 3-nitrotyrosine levels using a benchtop ion trap mass spectrometry method. (2005) (23)
- New targets of high-density lipoprotein therapy (2007) (22)
- Plaque Calcification. (2019) (21)
- The emerging role of plasma lipidomics in cardiovascular drug discovery (2012) (21)
- Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre study (2022) (21)
- Inflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging. (2015) (21)
- Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome (2018) (21)
- Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGER. (2013) (21)
- Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects. (2021) (21)
- A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. (2016) (21)
- Mental Health and Psychosocial Challenges in the COVID-19 Pandemic: Food for Thought for Cardiovascular Health Care Professionals (2020) (20)
- A Prospective, Randomized Trial of Single-Drug Versus Dual-Drug Immunosuppression in Heart TransplantationClinical Perspective (2011) (20)
- The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial: to believe or not to believe? (2012) (20)
- Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes (2012) (20)
- Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction (2017) (20)
- The relationship between coronary artery distensibility and fractional flow reserve (2017) (20)
- Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients. (2014) (19)
- Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease (2020) (19)
- To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis. (2015) (19)
- The ASTEROID trial: coronary plaque regression with high-dose statin therapy. (2006) (19)
- Multimodality Intravascular Imaging of High-Risk Coronary Plaque. (2021) (18)
- A Systematic Review and Meta-analysis of Gender Differences in Long-term Mortality and Cardiovascular Events in Peripheral Artery Disease. (2020) (18)
- Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome (2021) (17)
- Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial (2018) (17)
- Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: An analysis from the VOYAGER database (2013) (17)
- The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis (2018) (17)
- Feasibility and Validity of Computed Tomography-Derived Fractional Flow Reserve in Patients With Severe Aortic Stenosis: The CAST-FFR Study. (2020) (17)
- PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical Outlook (2017) (16)
- Cardiac Computed Tomography Radiomics for the Non-Invasive Assessment of Coronary Inflammation (2021) (16)
- High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes (2017) (16)
- Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study (2007) (16)
- Rationally Designed Probe for Reversible Sensing of Zinc and Application in Cells (2017) (16)
- Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER. (2012) (16)
- Current state-of-play in spontaneous coronary artery dissection. (2019) (16)
- Targeting low‐density lipoprotein cholesterol with PCSK9 inhibitors (2017) (16)
- Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications (2020) (16)
- Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN. (2016) (16)
- Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease (2021) (15)
- Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study). (2005) (15)
- HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis. (2016) (15)
- Coronary angiography for follow-up of heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade. (2007) (15)
- Vasculogenic properties of adventitial Sca-1+CD45+ progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis (2019) (15)
- The Extent of Aortic Atherosclerosis Predicts the Occurrence, Severity, and Recovery of Acute Kidney Injury After Transcatheter Aortic Valve Replacement: A Volumetric Multislice Computed Tomography Analysis (2018) (15)
- Clinical trials with cholesteryl ester transfer protein inhibitors (2016) (15)
- HDL: still a target for new therapies? (2008) (15)
- Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries (2009) (15)
- CETP‐Inhibition and HDL‐Cholesterol: A Story of CV Risk or CV Benefit, or Both (2018) (15)
- Plaque progression in coronary arteries with minimal luminal obstruction in intravascular ultrasound atherosclerosis trials. (2010) (15)
- The relationship between segmental wall shear stress and lipid core plaque derived from near-infrared spectroscopy. (2018) (15)
- Induction of obesity impairs reverse cholesterol transport in ob/ob mice (2018) (15)
- Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond (2016) (15)
- Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer? (2007) (14)
- Lowering triglycerides to modify cardiovascular risk: will icosapent deliver? (2015) (14)
- Coronary artery calcium scoring in cardiovascular risk assessment of people with family histories of early onset coronary artery disease. (2020) (14)
- Exploring the Roles of CREBRF and TRIM2 in the Regulation of Angiogenesis by High-Density Lipoproteins (2018) (14)
- High-density lipoprotein cholesterol associated with change in coronary plaque lipid burden assessed by near infrared spectroscopy. (2017) (14)
- CETP Inhibition in CVD Prevention: an Actual Appraisal (2016) (14)
- Intravascular Ultrasound and Near-Infrared Spectroscopic Characterization of Thin-Cap Fibroatheroma. (2017) (14)
- Coronary Atherosclerotic Plaque Regression (2022) (14)
- Rationale and design of a trial to personalize risk assessment in familial coronary artery disease (2018) (13)
- Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST‐elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial (2018) (13)
- Exploring the relationship between biomechanical stresses and coronary atherosclerosis. (2020) (13)
- 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques. (2020) (13)
- An organic fluorophore-nanodiamond hybrid sensor for photostable imaging and orthogonal, on-demand biosensing (2017) (13)
- Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy. (2013) (13)
- Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial (2020) (13)
- Aortic atheroma burden predicts acute cerebrovascular events after transcatheter aortic valve implantation: insights from volumetric multislice computed tomography analysis. (2016) (13)
- Statin-induced coronary artery disease regression rates differ in men and women (2015) (13)
- Bismuth complexes containing Mn(CO)5 and Re(CO)5 fragments. Synthetic studies and structural characterisation by solid- and solution-state extended X-ray absorption fine structure spectroscopy (1991) (13)
- High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility. (2018) (13)
- Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation Study (2015) (13)
- Lipid pharmacotherapy for treatment of atherosclerosis (2014) (13)
- Ultrathin monolithic 3D printed optical coherence tomography endoscopy for preclinical and clinical use (2020) (12)
- The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE (2019) (12)
- Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial (2012) (12)
- Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. (2012) (12)
- Cardiovascular bioimaging of nitric oxide: Achievements, challenges, and the future (2020) (12)
- Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial (2022) (12)
- Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies. (2016) (12)
- Taking the next steps to implement polygenic risk scoring for improved risk stratification and primary prevention of coronary artery disease. (2020) (11)
- The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events (2016) (11)
- Brain natriuretic peptides as biomarkers for atherosclerosis. (2008) (11)
- 217 IMPACT OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITION ON NUCLEAR MAGNETIC RESONANCE DERIVED LIPOPROTEIN PARTICLE PARAMETERS (2011) (11)
- Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes. (2022) (11)
- The mystery of evacetrapib - why are CETP inhibitors failing? (2020) (11)
- Diabetic dyslipidemia: extending the target beyond LDL cholesterol (2010) (11)
- Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease. (2021) (11)
- Non-hyperaemic pressure ratios to guide percutaneous coronary intervention (2020) (10)
- Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis. (2021) (10)
- CLINICAL PREDICTORS AND SEQUELAE OF COMPUTED TOMOGRAPHY DEFINED LEAFLET THROMBOSIS FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT AT MEDIUMTERM FOLLOW‐UP (2021) (10)
- Evolving targets for lipid-modifying therapy (2014) (10)
- Gender Differences in Healthy Lifestyle Adherence Following Percutaneous Coronary Intervention for Coronary Artery Disease. (2020) (10)
- 3D-Printed Micro Lens-in-Lens for In Vivo Multimodal Microendoscopy. (2022) (10)
- Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia (2010) (10)
- Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events. (2020) (10)
- Lessons from Coronary Intravascular Ultrasound on the Importance of Raising High-Density Lipoprotein Cholesterol (2010) (10)
- Recent trends in coronary intravascular ultrasound: Tracking atherosclerosis, pursuit of vulnerable plaques, and beyond (2006) (10)
- [Assessment of progression and regression of coronary atherosclerosis by intravascular ultrasound. A new paradigm shift?]. (2006) (10)
- Management of acute coronary syndrome in the very elderly (2016) (10)
- Relationship between changes in coronary atherosclerotic plaque burden measured by intravascular ultrasound and cardiovascular disease outcomes: a systematic literature review (2016) (10)
- In vivo visualization of lipid coronary atheroma with intravascular near-infrared spectroscopy (2017) (10)
- The complex intersection of inflammation and oxidation: implications for atheroprotection. (2008) (9)
- High-Energy Diet and Shorter Light Exposure Drives Markers of Adipocyte Dysfunction in Visceral and Subcutaneous Adipose Depots of Psammomys obesus (2019) (9)
- Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease (2021) (9)
- Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis (2015) (9)
- Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial (2021) (9)
- Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy. (2019) (9)
- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. (2023) (9)
- Radiomics-Based Precision Phenotyping Identifies Unstable Coronary Plaques From Computed Tomography Angiography. (2022) (9)
- Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in Australia (2020) (9)
- Treating Dyslipidemia in Type 2 Diabetes. (2018) (9)
- Progression of coronary atherosclerosis in patients without standard modifiable risk factors (2020) (9)
- Rosuvastatin and progression of atherosclerosis (2008) (9)
- Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular Ultrasound. (2020) (9)
- Implications of GLAGOV study (2017) (8)
- Strategies for the development of new PPAR agonists in diabetes (2010) (8)
- Intravascular ultrasound in the current percutaneous coronary intervention era. (2006) (8)
- Effectiveness of discharge education strategies versus usual care on clinical outcomes in acute coronary syndrome patients: a systematic review. (2020) (8)
- Genome-wide Polygenic Score and Cardiovascular Outcomes with Evacetrapib in Patients with High-risk Vascular Disease: A Nested Case-control Study. (2020) (8)
- VEGFR2 is activated by high‐density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia (2018) (8)
- Current imaging modalities for atherosclerosis (2012) (8)
- Favorable Impact on LDL Particle Size in Response to Treatment With Pioglitazone is Associated With Less Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes. (2015) (8)
- The Australian Cardiovascular Alliance-Towards an Integrated Whole-of-Nation Strategy to Address Our Major Health Burden. (2019) (8)
- Aortic distensibility is associated with both resting and hyperemic coronary blood flow. (2019) (8)
- Imaging progression of coronary atherosclerosis. (2013) (8)
- Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial (2021) (8)
- Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk (2011) (8)
- The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study (2017) (8)
- Investigating the long-term legacy of statin therapy. (2017) (8)
- Exploring the natural history of atherosclerosis with intravascular ultrasound (2007) (8)
- Statins targeting inflammation by lowering low-density lipoprotein? (2007) (8)
- Coronary Endothelium-Dependent Vasoreactivity and Atheroma Volume in Subjects With Stable, Minimal Angiographic Disease Versus Non–ST-Segment–Elevation Myocardial Infarction: An Intravascular Ultrasound Study (2013) (7)
- Anacetrapib as a potential cardioprotective strategy (2017) (7)
- Three‐ and 6‐month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug‐eluting stent: The ANCHOR study (2018) (7)
- Is spontaneous coronary artery dissection (SCAD) related to vascular inflammation and epicardial fat? -insights from computed tomography coronary angiography. (2020) (7)
- Serial Coronary Plaque Assessment Using Computed Tomography Coronary Angiography: A Comparison With Intravascular Ultrasound (2019) (7)
- Progression of coronary atherosclerosis in African-American patients. (2013) (7)
- Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure (2017) (7)
- Myeloperoxidase modification of high-density lipoprotein suppresses human endothelial cell proliferation and migration via inhibition of ERK1/2 and Akt activation. (2018) (7)
- Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound (2019) (7)
- Anti-Inflammatory Effects of Colchicine on Oxidised Low-Density Lipoproteins and Cholesterol Crystal-Induced Macrophage Activation in vitro (2017) (7)
- CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome (2015) (7)
- High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trials. (2009) (7)
- The Riskier Lipid: What Is on the HORIZON for Lipoprotein (a) and Should There Be Lp(a) Screening for All? (2021) (7)
- Plaque burden, microstructures and compositions underachieving very low LDL-C levels (2017) (7)
- Apo A-I Modulating Therapies (2011) (6)
- The New Face of Hyperlipidemia and the Role of PCSK9 Inhibitors (2019) (6)
- Rivaroxaban With or Without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS Trial (2019) (6)
- Lipid Lowering Therapy to Modify Plaque Microstructures: Insights from Optical Coherence Tomography Imaging (2017) (6)
- Epicardial and subcutaneous adipose tissue in Indigenous and non-Indigenous individuals: Implications for cardiometabolic diseases. (2019) (6)
- The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement. (2021) (6)
- The Emerging Role of CT-Based Imaging in Adipose Tissue and Coronary Inflammation (2021) (6)
- Renal Denervation: An Update (2016) (6)
- Imaging: Focusing light on the vulnerable plaque (2016) (6)
- Status of PCSK9 Monoclonal Antibodies in Australia. (2019) (6)
- Abstract 12252: Effects of the Cholesteryl Ester Transfer Protein Inhibitor, Evacetrapib, Administered as Monotherapy or in Combination With Statins on Cholesterol Efflux and HDL Particles in Patients With Dyslipidemia (2014) (6)
- Modeling Statin-Induced Reductions of Cardiovascular Events in Primary Prevention: A VOYAGER Meta-Analysis (2018) (6)
- Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry (2022) (6)
- Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy (2019) (6)
- Kidney Disease in Diabetes [chapter 3] (2014) (6)
- Eff ects of fi brates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (6)
- Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study (2021) (6)
- Atherosclerotic plaque reduction: blood pressure, dyslipidemia, atherothrombosis. (2008) (6)
- Coronary atheroma composition and its association with segmental endothelial dysfunction in non-ST segment elevation myocardial infarction: novel insights with radiofrequency (iMAP) intravascular ultrasonography (2015) (6)
- Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Vulnerable Plaque Features With Statin Therapy in Diabetic Patients With Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis. (2018) (6)
- Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?Response to Barter et al (2015) (6)
- Achieving better modulation of coronary atherosclerosis: its understanding, visualization and treatment. (2016) (6)
- Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people (2021) (6)
- Efficacy and Safety of Triplet Therapy With Bempedoic Acid, Ezetimibe, and Atorvastatin in Patients with Hypercholesterolemia (2019) (5)
- Ongoing challenges for pharmacotherapy for dyslipidemia (2015) (5)
- A Novel Ruthenium-based Molecular Sensor to Detect Endothelial Nitric Oxide (2019) (5)
- Provincial road condition and round wood timber transport in South Africa (2006) (5)
- The Keeping on Track Study: Exploring the Activity Levels and Utilization of Healthcare Services of Acute Coronary Syndrome (ACS) Patients in the First 30-Days after Discharge from Hospital (2019) (5)
- Mendelian Randomization Study of ACLY and Cardiovascular Disease. Reply. (2020) (5)
- Strategies to promote HDL-C: an emerging therapeutic target. (2005) (5)
- Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability (2014) (5)
- Update in Therapeutic Approaches to Plaque Stabilization (2014) (5)
- Management of dyslipidemia in patients with diabetes (2011) (5)
- Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis (2016) (5)
- Combining whispering gallery mode lasers and microstructured optical fibers for in-vivo biosensing applications (2013) (5)
- Abstract 5052: Lowering of the Triglyceride/HDL Cholesterol Ratio Predicts the Benefit of Pioglitazone on Progression of Coronary Atherosclerosis in Diabetic Patients (2008) (5)
- Familial Hypercholesterolemia in a Healthy Elderly Population. (2020) (5)
- Circadian disruption by short light exposure and a high energy diet impairs glucose tolerance and increases cardiac fibrosis in Psammomys obesus (2021) (5)
- Previous Pre-Eclampsia, Gestational Diabetes and Hypertension Place Women at High Cardiovascular Risk: But Do We Ask? (2020) (5)
- Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome (2018) (5)
- Women With Spontaneous Coronary Artery Dissection Are at Increased Risk of Iatrogenic Coronary Artery Dissection. (2020) (5)
- Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography (2015) (5)
- Is it time for HDL to change its tune? (2013) (5)
- Role of imaging end points in atherosclerosis trials: focus on intravascular ultrasound (2007) (5)
- Good Heart: Telling Stories of Cardiovascular Protective and Risk Factors for Aboriginal Women. (2020) (5)
- Results of the GLAGOV trial (2017) (5)
- Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects (2020) (5)
- "Framing" the vessel: the critical importance of volumetric analysis during serial intravascular imaging studies. (2012) (5)
- Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease (2022) (5)
- Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment–Elevated Myocardial Infarction (2022) (5)
- Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial (2019) (5)
- Coronary B2-Adrenoreceptors Mediate Endothelium-dependent Vasoreactivity in Humans: Novel Insights from an In Vivo Intravascular Ultrasound Study (2011) (5)
- Variations in coronary lumen dimensions measured in vivo. (2012) (4)
- Response to Comment on Stegman et al. High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN. Diabetes Care 2014;37:3114–3120 (2015) (4)
- The fish-oil paradox (2020) (4)
- Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein. (2016) (4)
- C-REACTIVE PROTEIN LEVELS MODULATE LIPOPROTEIN(A)-ASSOCIATED CARDIOVASCULAR RISK IN OPTIMALLY-TREATED PATIENTS WITH HIGH-RISK VASCULAR DISEASE (2019) (4)
- Predicting the future (1997) (4)
- INTRAVASCULAR ULTRASOUND EVALUATION OF THE EFFECT OF ROSUVASTATIN VERSUS ATORVASTATIN ON PROGRESSION OF CORONARY ATHEROSCLEROSIS: DESIGN OF THE SATURN STUDY (2008) (4)
- High-Density Lipoprotein Infusions. (2018) (4)
- Impact of Side-Branch Predilation on Angiographic Outcomes in Non-Left Main Coronary Bifurcation Lesions. (2020) (4)
- Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial. (2019) (4)
- Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging (2022) (4)
- Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. (2018) (4)
- Adherence to activity monitoring devices or smartphone applications for improving physical activity in adults with cardiovascular disease: a systematic review protocol. (2018) (4)
- Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis. (2021) (4)
- Noninvasive Assessment of Cardiopulmonary Reserve: Toward Early Detection of Pulmonary Vascular Disease (2017) (4)
- What role for lipoprotein(a) in clinical practice? (2017) (4)
- Variability of LDL-C response with different doses of simvastatin, atorvastatin and rosuvastatin: Results from voyager (2014) (4)
- Lipid biomarkers and cardiovascular risk: which path to take at the fork in the road? (2015) (4)
- Lipid Lowering in Acute Coronary Syndrome: Is Treatment Early Enough? (2018) (4)
- Abstract 12156: Greater Regression of Coronary Atherosclerosis With the Pre-Beta High-Density Lipoprotein Mimetic CER-001 in Patients With More Extensive Plaque Burden (2015) (4)
- Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS. (2015) (4)
- Predicting the future: challenges moving forward for arterial imaging. (2012) (4)
- Emerging role of intravascular ultrasound in the assessment of experimental anti-atherosclerotic therapies. (2006) (4)
- Will Big Data Shine Light at the End of the Tunnel for HDL? (2016) (4)
- Chronic kidney disease and coronary atherosclerosis: evidences from intravascular imaging (2019) (3)
- High-Density Lipoproteins and Cardiovascular Disease (2020) (3)
- Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease. (2021) (3)
- RELATIONSHIP BETWEEN UNDERLYING PLAQUE MORPHOLOGY EVALUATED BY NEAR-INFRARED SPECTROSCOPY AND THE DEGREE OF CORONARY ARTERY STENOSIS: THE COLOR REGISTRY (2018) (3)
- Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry. (2022) (3)
- Suspected hypersensitivity reaction following drug-eluting stent implantation. Novel insights with optical coherence tomography. (2012) (3)
- Radiomics-based Precision Phenotyping Identifies Unstable Coronary Plaques From Computed Tomography Angiography (2021) (3)
- Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study. (2012) (3)
- Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression. (2022) (3)
- Comparative effects of cholesteryl ester transfer protein inhibition, statin and ezetimibe therapy on atherogenic and protective lipid factors: The accentuate trial (2016) (3)
- PERICORONARY ADIPOSE TISSUE COMPUTED TOMOGRAPHY ATTENUATION IN DIFFERENT STAGES OF CORONARY ARTERY DISEASE: A CROSS-SECTIONAL STUDY (2020) (3)
- Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity (2022) (3)
- Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial. (2022) (3)
- Vitamin D and Cardiovascular Disease. (2018) (3)
- Cholesterol crystal-induced coronary inflammation: Insights from optical coherence tomography and pericoronary adipose tissue computed tomography attenuation. (2019) (3)
- Statin Effects on Both Low-Density Lipoproteins and High-Density Lipoproteins: Is There a Dual Benefit? (2010) (3)
- Abstract 1391: Atherogenic Dyslipidemia Predicts Accelerated Progression of Atherosclerosis in Patients with Coronary Artery Disease (2007) (3)
- Awareness of Familial Hypercholesterolemia Among Healthcare Providers Involved in the Management of Acute Coronary Syndrome in Victoria, Australia (2019) (3)
- An update on emerging drugs for the treatment of hypercholesterolemia (2021) (3)
- Residual Risk and Biology of the Disease: Implications for Plaque Imaging (2014) (3)
- Residual Risk and Biology of the Disease: Implications for Plaque Imaging (2014) (3)
- NSAID Use and Cardiovascular Disease - A Cautionary Tale. (2017) (3)
- The role of intracoronary imaging in translational research. (2020) (3)
- ORAL CALCIUM SUPPLEMENTS ASSOCIATE WITH SERIAL CORONARY CALCIFICATION: INSIGHTS FROM INTRAVASCULAR ULTRASOUND (2019) (3)
- Tackling cardiometabolic risk in the Asia Pacific region (2020) (3)
- Niacin’s effect on cardiovascular risk: Have we finally learned our lesson? (2014) (3)
- Quantitative and Qualitative Coronary Plaque Assessment Using Computed Tomography Coronary Angiography: A Comparison With Intravascular Ultrasound. (2020) (3)
- Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial. (2021) (3)
- The impact of lumen size and microvascular resistance on Fourier-domain optical coherence tomography (FD-OCT) coronary measurements. (2014) (3)
- Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels (2022) (3)
- Bromodomain and Extraterminal Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection (Pre-Clinical) (2020) (3)
- Men and women--similar but not identical: insights into LDL-lowering therapy in women from the Cholesterol Treatment Trialists Collaboration. (2015) (3)
- Comparing Coronary Atheroma Progression Rates and Coronary Events in the United States, Canada, Latin America, and Europe. (2016) (3)
- Optical coherence tomography for serial in vivo imaging of aortic plaque in the rabbit: a preliminary experience (2015) (3)
- Sex Differences in Epidemiology, Care, and Outcomes in Patients With Acute Chest Pain. (2023) (2)
- Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development (2009) (2)
- Abstract 3328: Baseline and Changes in Atheroma Volume Predict Clinical Outcome in Patients with Coronary Artery Disease: Insights from ILLUSTRATE (2007) (2)
- Pioglitazone vs Glimepiride in the PERISCOPE Trial—Reply (2008) (2)
- Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis. (2021) (2)
- Managing Cardiovascular Complications in Diabetes: Betteridge/Managing Cardiovascular Complications in Diabetes (2014) (2)
- The time for lipoprotein(a) based intervention has arrived: where will the light shine? (2019) (2)
- Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging Drugs (2019) (2)
- Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs (2017) (2)
- Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36 (2022) (2)
- Patients' satisfaction with information at discharge (2018) (2)
- Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis (2022) (2)
- Exposing the complexity of HDL. (2007) (2)
- Immune Checkpoint Inhibitor Therapy in Oncology (2022) (2)
- REGRESSION OF CORONARY ATHEROMA VOLUME IN PATIENTS RECEIVING HIGH DOSE STATIN THERAPY: ANALYSIS OF THE SATURN STUDY (2012) (2)
- World Heart Federation Cholesterol Roadmap 2022 (2022) (2)
- Taking the lid off the pot on marijuana and cardiovascular disease (2017) (2)
- Abstract 17400: Lipoprotein(a) is a Determinant of Residual Cardiovascular Risk in the Setting of Optimal LDL-C in Statin-Treated Patients With Atherosclerotic Cardiovascular Disease (2017) (2)
- Establishing an Australian and New Zealand Registry for Patients with Familial Hypercholesterolaemia (2013) (2)
- New drugs for HDL-C disorders: the beginning. (2014) (2)
- Fractional Flow Reserve following Percutaneous Coronary Intervention (2020) (2)
- The lack of evidence for the effectiveness of discharge education on clinical outcomes in acute coronary syndrome patients: a systematic review. where to from here? (2018) (2)
- Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia (2021) (2)
- Treating stable ischemic heart disease with percutaneous coronary intervention - The debate continues. (2012) (2)
- Atherosclerotic Cardiovascular Risk With Combination Avelumab and Axitinib. (2022) (2)
- Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation (2022) (2)
- The effect of South African provincial road condition on the efficiency of forest product transport (2004) (2)
- EFFECTS OF AN APOLIPOPROTEIN A-1 INDUCER ON PROGRESSION OF CORONARY ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS IN PATIENTS WITH ELEVATED INFLAMMATORY MARKERS (2014) (2)
- Intracoronary optical coherence tomography: are we getting too close to the light? (2013) (2)
- Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial (2019) (2)
- A HIGHLY BIOAVAILABLE OMEGA-3 FREE-FATTY ACID REDUCES NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL IN HIGH-RISK PATIENTS TREATED WITH A STATIN AND RESIDUAL HYPERTRIGLYCERIDEMIA (ESPRIT TRIAL) (2013) (2)
- Surgical and percutaneous management of aboriginal Australians with rheumatic heart disease: Timeliness and concordance between practice and guidelines. (2021) (2)
- SEX-RELATED DIFFERENCE IN THE REGRESSION OF CORONARY ATHEROSCLEROSIS WITH THE PCSK9 INHIBITOR, EVOLOCUMAB: INSIGHTS FROM GLAGOV (2018) (2)
- Acute high-density lipoprotein therapies (2015) (2)
- Combining cholesterol-lowering strategies with imaging data: a visible benefit? (2018) (2)
- Monitoring the Response to Statin Therapy: One Scan at a Time. (2018) (2)
- Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial (2019) (2)
- Heart Disease in Women: Where Are We Now and What is The Future? (2021) (2)
- PCSK9 Inhibitors: Treating the Right Patients in Daily Practice (2017) (2)
- High-Density Lipoprotein: Is the Good Cholesterol Turning Bad? (2011) (2)
- RESULTS FROM THE FENOFIBRIC ACID ON CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS WITH TYPE IIB DYSLIPIDEMIA WITH RESIDUAL RISK IN ADDITION TO ATORVASTATIN THERAPY (FIRST) TRIAL (2013) (2)
- Attainment of the anticipated >=50% reduction in LDL-C in the four ACC/AHA guidelines statin benefit groups: A voyager meta-analysis (2014) (2)
- Left main coronary arterial endothelial function and heterogenous segmental epicardial vasomotor reactivity in vivo: novel insights with intravascular ultrasonography. (2014) (1)
- Computed tomography imaging for subclinical leaflet thrombosis following surgical and transcatheter aortic valve replacement. (2022) (1)
- Agreement between iFR and other non-hyperaemic pressure ratios in severe aortic stenosis. (2022) (1)
- Abstract 13442: Aging, Risk Factors and Progression of Coronary Atherosclerosis (2010) (1)
- Statins and CETP Inhibitors: Anacetrapib and Evacetrapib: The Last Hope? (2015) (1)
- Shining Light on the Impact of Air Pollution. (2021) (1)
- Abstract 14843: Intracoronary Salbutamol is a Novel Endothelium-Dependent Coronary Vasodilator -- Mechanistic Insights From an in vivo Intravascular Ultrasound (IVUS) Study (2010) (1)
- Management of Severe Dyslipidaemia: Role of PCSK9 Inhibitors. (2018) (1)
- Future requirement for arterial wall imaging modalities in the evaluation of novel anti-atherosclerotic therapies (2010) (1)
- Quality of Warfarin Anticoagulation for Atrial Fibrillation in Indigenous and Non-Indigenous Australians (2017) (1)
- RELATIONSHIP BETWEEN CORONARY MICRO- AND MACROVASCULAR MEASURES IN WOMEN WITH CHEST PAIN WITHOUT SIGNIFICANT CORONARY ARTERY DISEASE: AN ANCILLARY SUBSTUDY FROM THE NHBLI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE) (2011) (1)
- 402 Role of Coronary Inflammation in High-Risk Plaque and Acute Coronary Syndrome in Patients With Stable Coronary Artery Disease: Insights from Pericoronary Adipose Tissue Attenuation (PCAT) on CTCA (2020) (1)
- Abstract 5051: Alteration of Atherogenic Lipoproteins by Statin Therapy in Patients With Diabetes in a Large Pooled Clinical Trial Database (2008) (1)
- Impact of Cardiac Rehabilitation Programs on 12-Month Outcomes: A Clinical Network Initiative (2018) (1)
- Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved (2022) (1)
- Artificial Intelligence-based Plaque Quantification From Coronary Computed Tomography Angiography Using Deep Learning: External Validation And Comparison With Intravascular Ultrasound (2021) (1)
- Achievement of combined goals of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol with three different statins: Results from VOYAGER (2014) (1)
- HbA1c, Coronary atheroma progression and cardiovascular outcomes (2022) (1)
- CARAT: will infusing a pre-beta high-density lipoprotein mimetic (CER-001) regress coronary atherosclerosis? (2017) (1)
- TCT-660 Multicenter Validation of a Near-infrared Spectroscopic Signature of Culprit Lesions Causing ST-segment Elevation Myocardial Infarction: The NIRSTEMI II Study (2013) (1)
- IMPACT OF MULTIPLE RISK FACTOR INTERVENTION ON PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (2011) (1)
- Impact of Cardiac Rehabilitation on Late Clinical Outcomes: Non–Attenders Versus Attenders On Behalf of the South Australian Public Hospital Cardiac Rehabilitation Service Providers (2018) (1)
- Abstract 13189: Cardiovascular Evaluation of the Selective BET Inhibitor, Apabetalone, in ACS Patients With Diabetes: Baseline Characteristics of the BETonMACE CV Outcomes Study (2018) (1)
- Health literacy and long-term health outcomes following myocardial infarction: protocol for a multicentre, prospective cohort study (ENHEARTEN study) (2022) (1)
- Practical Approach to Diagnosis & Management of Lipid Disorders (2009) (1)
- Studying coronary plaque regression with IVUS. (2006) (1)
- Predictors of Atheroembolic Complications During Saphenous Vein Graft Percutaneous Coronary Intervention (2007) (1)
- Is Lp(a) ready for prime time? (2014) (1)
- New Cardiovascular Risk Assessment Techniques for Primary Prevention: JACC Review Topic of the Week. (2022) (1)
- Atherosclerosis imaging in drug development (2007) (1)
- Using genetic to guide treatment and drug development in cardiovascular medicine: time to reveal the proof in the pudding. (2019) (1)
- Prosthesis Geometrical Predictors of Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement With Intra-Annular Prostheses. (2022) (1)
- TAPERING AND DISCONTINUATION OF BACKGROUND THERAPIES DURING THE TRANSITION TO RILONACEPT MONOTHERAPY IN RHAPSODY, A PHASE 3 CLINICAL TRIAL OF RILONACEPT IN PATIENTS WITH RECURRENT PERICARDITIS (2021) (1)
- TCT-266 Frequency of Spotty Calcification Among Lipid-Core Plaques Using Combined Intracoronary Near-infrared Spectroscopy and Intravascular Ultrasound (2012) (1)
- Impact of statins on atherosclerotic plaque. (2007) (1)
- Multi-Detector Computed Tomography (MDCT) and Magnetic Resonance Imaging (MRI) Non-Invasively Quantifies Saphenous Vein Graft Atherosclerotic Plaque: A Comparison with Intravascular Ultrasound (IVUS) (2007) (1)
- P5355Impact of evacetrapib on glyvemic control: results from the accelerate trial (2017) (1)
- Can we revive CETP-inhibitors for the prevention of cardiovascular disease? (2022) (1)
- Imaging Coronary Atherosclerosis (2014) (1)
- Statins for Primary Prevention in the Elderly: The Importance of Rigorous Evidence. (2020) (1)
- Comparison of Intravascular Ultrasound Assessment of Segmental Coronary Vasomotor Responses with Quantitative Coronary Angiography (2010) (1)
- Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician (2022) (1)
- Variations in Coronary Lumen Dimensions Measured In Vivo: Quantitative Comparisons Between Intravascular Ultrasound, Fourier Domain Optical Coherence Tomography and Three Dimensional Quantitative Coronary Angiography (2011) (1)
- Aggressive treatment of high-density lipoprotein cholesterol. (2005) (1)
- Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease (2022) (1)
- TCT-648 Coronary Atheroma Composition Predicts Endothelial Dysfunction in Non-ST Segment Myocardial Infarction: Novel Insights with Radiofrequency (iMAP) Intravascular Ultrasonography (IVUS) (2013) (1)
- HYPERGLYCEMIA AND OXIDATION IMPAIRS THE IMPACT OF HIGH-DENSITY LIPOPROTEINS ON ENDOTHELIAL CELL GROWTH AND MIGRATION. (2010) (1)
- Clinical guidelines on hyperlipidaemia: recent developments, future challenges and the need for an Australian review. (2015) (1)
- Rationale and approach to evaluation of the impact of medical therapies on progression of atherosclerosis with arterial wall imaging (2010) (1)
- Translational application of in vivo imaging and analysis of atherosclerotic plaque vulnerability assessment (2013) (1)
- Implementation and prospective evaluation of the Country Heart Attack Prevention model of care to improve attendance and completion of cardiac rehabilitation for patients with cardiovascular diseases living in rural Australia: a study protocol (2022) (1)
- Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development (2022) (1)
- The cost‐effectiveness of coronary calcium score‐guided statin therapy initiation for Australians with family histories of premature coronary artery disease (2023) (1)
- CARDIAC MAGNETIC RESONANCE IMAGING FOR GUIDING DECISION-MAKING ON TREATMENT DURATION: DATA FROM RHAPSODY, A PHASE 3 CLINICAL TRIAL OF RILONACEPT IN RECURRENT PERICARDITIS (2021) (1)
- Coronary computed tomography angiography-based assessment of vascular inflammation in patients with obstructive sleep apnoea and coronary artery disease. (2021) (1)
- Targeting triglycerides to lower residual cardiovascular risk (2022) (1)
- Will genetic studies deliver the next generation of cardioprotective therapies? (2017) (1)
- 8B.03: ATHEROMA PROGRESSION IN RENAL ARTERIES AFTER CATHETER-BASED RENAL ARTERY DENERVATION USING SERIAL VOLUMETRIC COMPUTED TOMOGRAPHY ANALYSIS ANALYSIS FROM THE ENLIGHTN 1 TRIAL (2015) (1)
- Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients (2022) (1)
- C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV (2020) (1)
- Homocysteine Levels, Paraoxonase 1 (PON1) Activity, and Cardiovascular Risk—Reply (2008) (1)
- Invasive Imaging Modalities and Atherosclerosis: The Role of Intravascular Ultrasound (2009) (1)
- Imaging coronary atherosclerosis: is there space for magnetic resonance imaging? (2013) (1)
- Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus (2009) (1)
- Breast arterial calcification and Epicardial adipose tissue volume but not density are independently associated with cardiovascular risk. (2022) (1)
- Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis-Reply. (2017) (1)
- Corrigendum to "Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis" [Clin. Biochem. 64 (2019) 24-29]. (2019) (1)
- BET PROTEIN INHIBITION AND COGNITION: A PRE-SPECIFIED SUBSTUDY OF THE BETONMACE PHASE 3 TRIAL EVALUATING APABETALONE IN PATIENTS WITH DIABETES AND ACUTE CORONARY SYNDROME (2019) (1)
- TCT-226 Comparison Of Endothelial Function In The Left Main Coronary Artery And Epicardial Arterial Segments (2012) (1)
- AGREEMENT BETWEEN IFR AND OTHER NON-HYPERAEMIC PRESSURE RATIOS IS NOT AFFECTED BY SEVERE AORTIC STENOSIS (2021) (1)
- Lipidomics: Opportunities to Identify New Causal Mechanisms and Therapeutics for Atherosclerosis (2013) (1)
- 425-P: Inhibition of miR-181c Rescues Diabetes-Impaired Angiogenesis (2019) (1)
- INTRACORONARY SALBUTAMOL, SEGMENTAL PLAQUE BURDEN AND FOCAL CORONARY ENDOTHELIAL FUNCTION: NOVEL MECHANISTIC INSIGHTS FROM AN IN VIVO INTRAVASCULAR ULTRASOUND STUDY (2011) (1)
- Assessment of Plaque Burden and Plaque Composition Using Intravascular Ultrasound (2011) (1)
- Characteristics of plaque microstructures in diabetic patients receiving metformin: frequency domain optical coherence tomography analysis (2015) (1)
- Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall. (2023) (1)
- Abstract 1195: Proatherogenic Impact of the ACAT Inhibitor Pactimibe in Patients with Coronary Artery Disease and Multiple Risk Factors: Insights from the ACTIVATE study (2006) (1)
- Machine Learning Integration Of Quantitative Plaque Features And Clinical Data Identifies Patients With Myocardial Infarction: A Prospective Study (2020) (1)
- High-density lipoprotein and atheroma monitoring (2008) (1)
- Deep Learning From Coronary Computed Tomography Angiography for Atherosclerotic Plaque and Stenosis Quantification and Cardiac Risk Prediction (2021) (1)
- High-Density Lipoprotein-Targeted Therapies-Not Dead Yet-Reply. (2018) (1)
- The impact of oral omega-3 fatty acid supplementation on acute vascular inflammation in a mouse model. (2017) (1)
- LARGER LIPID POOLS ASSOCIATE WITH FEATURES OF PLAQUE VULNERABILITY ON OPTICAL COHERENCE TOMOGRAPHY (2013) (1)
- Findings of clinical trials that evaluate the impact of medical therapies on progression of atherosclerosis (2010) (1)
- Murine Adventitial Sca-1+CD45+ Progenitor Cells are Proangiogenic and Give Rise to Vasa Vasorum in Atherosclerosis (2016) (1)
- Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk-Reply. (2021) (1)
- ELEVATED LEVELS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO PREDICTS INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN HIGH RISK PATIENTS: INSIGHTS FROM ACCELERATE (2018) (1)
- Evaluation of human coronary vasodilator function predicts future coronary atheroma progression (2018) (1)
- Low Coronary Arterial Wall Shear Stress is Associated with Endothelial Dysfunction and Expansive Arterial Remodeling In Vivo: Implications for Plaque Vulnerability (2012) (1)
- Omega-3 Fatty Acids Reduce Acute Vascular Inflammation but do not Affect Atherosclerotic Plaque Burden or Composition (2017) (1)
- Determinants of Plaque Progression Despite Very Low Low-Density Lipoprotein–Cholesterol Levels With the PCSK9 Inhibitor, Evolocumab (2021) (1)
- Targeting obesity, diabetes and the metabolic syndrome: are we trying to close the barn door after the horse bolted? (2014) (1)
- Controversies on HDL: should it be a target biomarker in patients with lipid disorders? (2014) (1)
- Protective lipid-lowering variants in healthy older individuals without coronary heart disease (2021) (1)
- Abstract 18791: Serum Ceruloplasmin Independently Predicts Cardiovascular Risk in Stable Cardiac Patients (2010) (1)
- Effectiveness of discharge education on outcomes in acute coronary syndrome patients: a systematic review protocol. (2018) (1)
- GREATER LIKELIHOOD OF REGRESSION OF CORONARY ATHEROSCLEROSIS WITH THE PCSK9 INHIBITOR, EVOLOCUMAB, IN PATIENTS WITH HIGHER LP(A) LEVELS (2018) (1)
- Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes. (2016) (1)
- pharmacological mechanisms and clinical efficacy (2013) (1)
- EFFECT OF LONGER-TERM ADMINISTRATION OF EVOLOCUMAB IN PATIENTS WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE: RESULTS OF THE GLAGOV OPEN LABELLED EXTENSION STUDY (2020) (1)
- Abstract 10453: Impact of Diabetes Duration on Atheroma Progression in Diabetic Patients with Coronary Artery Disease: Insights From Serial Intravascular Ultrasound (2011) (1)
- Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes. (2016) (1)
- Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes. (2022) (1)
- Mechanisms of coronary ischaemia in women: Are we any closer to deciphering the code? (2018) (1)
- Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective (2021) (1)
- Biological Sensing of Nitric Oxide in Macrophages and Atherosclerosis Using a Ruthenium-Based Sensor (2022) (1)
- An organic fluorophore-nanodiamond hybrid sensor for photostable imaging and orthogonal, on-demand biosensing (2017) (1)
- Biosensors for detecting stress in developing embryos (2016) (1)
- Comparison between different approaches to evaluate fibrous cap thickness in sequential OCT studies. (2020) (1)
- 3911Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE (2017) (1)
- The Association of Triglyceride/High-Density Lipoprotein Cholesterol Ratio with Lipidic Plaque Features in Diabetic Patients Receiving a Statin: Frequency Domain Optical Coherence Tomography Analysis (2016) (0)
- Can CMR Elucidate the Cardiovascular Benefit of SGLT2 Inhibitors? (2021) (0)
- Abstract: P1154 IN VITRO PROPERTIES OF AN APOLIPOPROTEIN A-I MIMETIC PEPTIDE (2009) (0)
- 782 FAVOURABLE IMPACT ON LIPID LEVELS OF INCREASING STATIN DOSE IN HIGH-RISK PATIENTS WITH VERY HIGH BASELINE LDL-C: RESULTS FROM VOYAGER (2011) (0)
- Serial changes in vessel walls of renal arteries after catheter-based renal artery denervation: insights from volumetric computed tomography analysis (2018) (0)
- Abstract 17446: Fasting Remnant Cholesterol Levels Predict Incident Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease: The ACCELERATE Trial (2017) (0)
- Self-renewing tissue-resident endothelial-macrophage progenitor cells originate from yolk sac and are a local source of inflammation and neovascularization in postnatal aorta (2021) (0)
- Altered Atheroprotective Properties of High-Density Lipoproteins in Adolescents with Chronic Inflammatory Disease (2013) (0)
- Diagnostic accuracy of reperfusion criteria following fibrinolysis for ST-elevation myocardial infarction. (2023) (0)
- GENDER SPECIFIC FACTORS ASSOCIATED WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS: INSIGHTS FROM ACCELERATE (2018) (0)
- TCT CONNECT-456 Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR) (2020) (0)
- Abstract 20126: CRP, Risk Factors and Major Adverse Cardiovascular Events: Insights From ACCELERATE (2017) (0)
- 484 Effect of Longer-Term Administration of Evolocumab in Patients With Angiographic Coronary Artery Disease: Results of the GLAGOV Open Label Extension Study (2020) (0)
- O061 The impact of luminal size and microvascular resistance on OCT measurements (2014) (0)
- 723 Colchicine Exerts Anti-Atherosclerotic and Plaque-Stabilising Effects in Mice by Inhibiting Macrophage Foam Cell Formation and Cholesterol Crystal-Induced NLRP3 Activation (2020) (0)
- 459Absence of Coronary Calcification is a Common and Reassuring Finding in Half of Intermediate Risk Patients with a Family History of CAD: Baseline Results from the CAUGHT-CAD Study (2017) (0)
- TCT-511 Two-year Clinical Results with the Angiolite® Drug-Eluting Stent: The ANCHOR Study. (2018) (0)
- AGGRESSIVE USE OF ANTI-ATHEROSCLEROTIC THERAPIES SLOWS PROGRESSION OF CORONARY ATHEROMA IN PATIENTS WITH A HISTORY OF CORONARY REVASCULARIZATION (2010) (0)
- The role of nutrition and environmental factors in management of familial hypercholesterolemia (2019) (0)
- 3P-0729 Periarterial collar induced pro-oxidant and proinflammatory changes are inhibited by reconstituted high density lipoprotein (2003) (0)
- CARDIOVASCULAR AND CARDIOMETABOLIC CLINICAL TRIAL LEADERSHIP AND COLLABORATION IN THE ASIA-PACIFIC REGION (2023) (0)
- Pulsatile torso: giant cardiomegaly from untreated tricuspid endocarditis (2018) (0)
- Abstract 3723: Pattern Of Arterial Remodeling In Association With Halting Progression Of Coronary Atherosclerosis With Pioglitazone In Diabetic Patients: Insights From The Periscope Study (2008) (0)
- A Novel Deep Learning Approach for Automated Diagnosis of Acute Ischemic Infarction on Computed Tomography (2018) (0)
- C-REACTIVE PROTEIN VARIABILITY AND CARDIOVASCULAR OUTCOMES IN OPTIMALLY-TREATED HIGH-RISK VASCULAR DISEASE (2020) (0)
- Tu-W16:1 HDL and the inhibition of inflammation in vivo (2006) (0)
- Relationship Between Coronary Atherosclerotic Plaque Burden Measured By Intravascular Ultrasound And Cardiovascular Disease Outcomes (2016) (0)
- Abstract 16193: Greater Benefit of Anti-Atherosclerotic Therapies in Patients with A Recent Acute Coronary Syndrome (2010) (0)
- Abstract 3779: Arterial Wall Remodeling in Response to Atheroma Regression with Very Intensive Lipid Lowering: Insights from the ASTEROID Trial (2006) (0)
- 910 Uptake and Utilisation of Intravascular Imaging to Guide Percutaneous Coronary Intervention: Insights from the Victorian Cardiac Outcomes Registry (2020) (0)
- Myocardial Infarction Is Associated With A Distinct Pericoronary Adipose Tissue Radiomic Phenotype: A Prospective Case-Control Study (2020) (0)
- Abstract 3724: Optimal Control of Both Lipids and Blood Pressure is Required for Maximal Regression of Coronary Atherosclerosis (2006) (0)
- Inflammatory Markers and Novel Risk Factors (2018) (0)
- Intracoronary Ultrasound in Assessing Efficacy of Cardiovascular Drugs (2010) (0)
- P6193Dalcetrapib reduces incident diabetes in patients with recent acute coronary syndrome (2019) (0)
- Computed Tomography Coronary Angiography (CTCA) Detected High Risk Plaques are a Predictor of Future Coronary Events – Insights from a Propensity Matched Study of Patients who have Undergone Invasive Coronary Angiography, Fractional Flow Reserve and CTCA (2019) (0)
- Abstract 3727: Progression of Coronary Atherosclerosis: Do ACE Inhibitors Make a Difference? (2006) (0)
- TCTAP A-003 Prosthesis Geometrical Predictors of Leaflet Thrombosis following Transcatheter Aortic Valve Replacement with Intra-annular Prostheses (0)
- Is Spontaneous Coronary Artery Dissection (SCAD) Related to Vascular Inflammation and Epicardial Fat? Insights from Novel Markers of Computed Tomography Coronary Angiography (2019) (0)
- PCSK9 Inhibitors in Hyperlipidemia: Current Status and Clinical Outlook (2017) (0)
- GREATER PROGRESSION OF CORONARY ATHEROSCLEROSIS IN AFRICAN-AMERICAN PATIENTS DESPITE THE USE OF ESTABLISHED MEDICAL THERAPIES (2011) (0)
- Insights from a virtual world. (2011) (0)
- Abstract 14913: Variable Effects on Lipid Transporting and Non-Lipid Transporting Functions of HDL in Young Patients With Chronic Inflammatory Arthritis (2013) (0)
- Abstract 5146: Statin Therapy Alters the Relationship Between Apolipoprotein B and Both LDL-C and Non-HDL-C in High-Risk Patients: Effect of Race and Ethnic Background (2008) (0)
- Direct head-to-head comparison of convolutional long short-term memory and transformer networks for artificial Intelligence-based quantification of atherosclerotic plaque and stenosis from coronary CT angiography (2023) (0)
- Abstract 315: Calcium Dose Dependently Influences Endothelial Cell Angiogenesis (2017) (0)
- Burden Measured by Intravascular Ultrasound Relationship Between Cardiovascular Risk Factors and Atherosclerotic Disease (2011) (0)
- ELEVATED PLASMA MYELOPEROXIDASE AS INDICATOR FOR VULNERABLE PLAQUE IN STABLE PATIENTS WITH SIGNIFICANT ATHEROSCLEROTIC BURDEN (2010) (0)
- Abstract 20280: Impact of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib on Cholesterol Efflux Capacity in High Risk Patients Within the ACCELERATE Trial (2016) (0)
- Ct-defined Leaflet Thrombosis (LT) Predicts Structural Valve Deterioration (SVD) Following TAVR (2021) (0)
- Quantitative but not Qualitative Computed Tomography Coronary Angiography High Risk Plaque Characteristics are Associated with Major Adverse Cardiovascular Events in Patients with Non-Significant Invasive Fractional Flow Reserve (2019) (0)
- Abstract 10439: Natural History of Echolucent Plaque in Stable Patients with Coronary Artery Disease: Insights From Intravascular Ultrasound (2011) (0)
- MS48 EFFECTS OF AGE AND STATIN DOSE ON LIPID LEVELS: RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS (2010) (0)
- Abstract 16232: Lipoprotein(a) is Not Associated With the Risk of Ischemic Cardiovascular Events Following Acute Coronary Syndrome (2016) (0)
- Abstract 1706: Elevated Plasma Myleoperoxidase as Indicator for Vulnerable Plaque in Stable Patients With Diabetes Mellitus (2009) (0)
- Abundance of Asialylated Glycans in Vascular Tissues Increases With the Plaque Burden in Atherosclerotic Rabbits (2018) (0)
- Tu-W16:4 A single infusion of lipid free APO A1 can rescue vascular inflammation (2006) (0)
- Primary and secondary prevention strategies in atherosclerosis (2016) (0)
- Abstract: 1496 DIFFERENT PATTERNS OF ARTERIAL REMODELING AND CALCIFICATION ASSOCIATED WITH ATHEROSCLEROSIS IN CORONARY AND PERIPHERAL VASCULAR TERRITORIES (2009) (0)
- Abstract 47: Tapering And Discontinuation Of Background Therapies During The Transition To Rilonacept Monotherapy In Rhapsody, A Phase 3 Clinical Trial Of Rilonacept In Patients With Recurrent Pericarditis (2022) (0)
- Abstract 17125: Predictors of Residual Plaque Progression Despite Achieving Low Levels of LDL-C With the PCSK9 Inhibitor, Evolocumab (2017) (0)
- Adverse Effects Associated with Varespladib in the VISTA-16 Trial (2013) (0)
- Longitudinal Assessment of Coronary Plaque Using Computed Tomography Coronary Angiography and Intravascular Ultrasound (2018) (0)
- Lower Plaque Lipid Content on Near-Infrared Spectroscopy in Statin-Treated Patients: Insights from the Color Registry (2016) (0)
- Intracoronary Optical Coherence Tomography (0)
- LESSONS FROM ARTERIAL WALL IMAGING TRIALS OF LIPID LOWERING (2017) (0)
- 196 INCREASING CIRCULATING CONCENTRATION OF ALL HDL PARTICLE SUBCLASSES IN HYPER-RESPONDERS TO APOLIPOPROTEIN A-I INDUCTION: INSIGHTS FROM THE ASSERT STUDY (2011) (0)
- DIMINISHED PAROXONASE-1 ACTIVITY, A MARKER OF DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, RECLASSIFIES STABLE CARDIAC PATIENTS AT HIGHER RISK FOR DEVELOPING MAJOR ADVERSE CARDIAC EVENTS (2010) (0)
- TCT-281 The Association Between Cholesterol Crystal And Features Of Plaque Vulnerability On Optical Coherence Tomography (2012) (0)
- 683: Core Lab Analysis of Intravascular Ultrasound Studies from the TICTAC Trial (Tacrolimus in Combination, Tacrolimus Alone Compared): Is There a Price To Pay for Monotherapy? (2009) (0)
- PROSTHESIS GEOMETRICAL PREDICTORS OF LEAFLET THROMBOSIS FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT WITH INTRA-ANNULAR PROSTHESES (2021) (0)
- Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations. (2023) (0)
- Associations Between Cardiovascular Burden, Gender and Depression in Indigenous Australians (2019) (0)
- Mechanisms of Vascular Disease: Current and emerging therapies in atheroprotection (2011) (0)
- Anandamide as a Marker of Human Disease TotheEditor:IntheirResearchLetter,DrHabayebandcol- (2017) (0)
- 01 - LIPOPROTEINS AND THEIR MODIFIED FORMS REGULATE EARLY STAGE VASCULAR SMOOTH MUSCLE CELL CALCIFICATION (2019) (0)
- A novel non-invasive pulmonary vasoreactive challenge utilising cardiac magnetic resonance imaging: comparison of subjects with and without pulmonary arterial hypertension (2015) (0)
- 2P-0467 Enhanced anti-inflammatory property of high density lipoprotein following infusion of chylomicron-like emulsions (2003) (0)
- 709 Strong Heart: It’s Time to Think Differently About Risk and Protective Factors for Aboriginal Women (2020) (0)
- Genetic Variants Related to Combined Exposure to both Lower Low- Density Lipoproteins and Lower Systolic Blood Pressure with Lifetime Risk of Cardiovascular Disease. JAMA Network Open, E1-E11 (2019) (0)
- EFFECTS OF THE EPIGENETIC BET-INHIBITOR SMALL MOLECULE APABETALONE ON COGNITION IN PATIENTS WITH DIABETES AND CARDIOVASCULAR DISEASE (2019) (0)
- Abstract 20260: Impact of Glycemic Control on Residual Cardiovascular Risk in Diabetic Patients Treated With Statin Therapy (2017) (0)
- The Association Between Cholesterol Crystal And Features Of Plaque Vulnerability On Optical Coherence Tomography (2016) (0)
- PRIOR CORONARY ARTERY BYPASS GRAFTING AND INCIDENT CARDIOVASCULAR EVENTS IN THE SETTING OF CONTEMPORARY MEDICAL THERAPY: INSIGHTS FROM ACCELERATE (2018) (0)
- Optical coherence tomography for serial in vivo imaging of aortic plaque in the rabbit (2015) (0)
- O099 Impact of High-dose Statins on Plaque Microstructures in Stable Patients with Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis (2014) (0)
- Short-Term Changes in Spotty Calcification and Burden of Coronary Atherosclerosis: Insights into the Interface Between Plaque Composition and Burden (2016) (0)
- Abstract: 1111 ANTI-INFLAMMATORY PROPERTIES OF RECONSITUTED HDL IN A CHRONIC MODEL OF INFLAMMATION (2009) (0)
- COMPARED TO INSULIN GLARGINE, TIRZEPATIDE REDUCES THE PREVALENCE OF THE METABOLIC SYNDROME IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK: POST-HOC ANALYSIS OF SURPASS-4 (2023) (0)
- Managing high risk diabetes patient with cardiovascular disease : What works , and what else (0)
- 783 EFFECT OF ROSUVASTATIN AND ATORVASTATIN DOSE ON LDL-C <70MG/DL GOAL ATTAINMENT IN PATIENTS WITH DIABETES MELLITUS: RESULTS FROM VOYAGER (2011) (0)
- LACK OF ASSOCIATION BETWEEN LDL-CHOLESTEROL, PLAQUE BURDEN AND LIPID-RICH PLAQUE IN CORONARY LESIONS REQUIRING PCI: THE COLOR REGISTRY (2016) (0)
- Doses of rosuvastatin, atorvastatin and simvastatin inducing an equipotent effect on LDL-C: Results from the voyager meta-analysis (2014) (0)
- 427 Utilisation of 320-slice Computed Tomography (CT) to Determine Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) following Transcatheter Aortic Valve Replacement (TAVR) (2020) (0)
- Pioglitazone vs Glimepiride in the PERISCOPE Trial. Authors' reply (2008) (0)
- O040 Changes in plaque composition with a novel apolipoprotein A-I inducer: insights from the assure study (2014) (0)
- LIPOPROTEIN (A) LEVELS PREDICT THE EXTENT OF OBSTRUCTIVE DISEASE AND LONGTERM CARDIOVASCULAR OUTCOME IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY WITH SUBOPTIMAL LIPID CONTOROL (2010) (0)
- Abstract 15543: Geographic Variations of Coronary Atheroma Progression and Clinical Events in Patients With Coronary Artery Disease (CAD) (2013) (0)
- 542 Incidence of Coronary Artery Vasculopathy Has Decreased with Modern Immunosuppression: Insights from Clinical Trials in Organ Transplantation (2011) (0)
- Regression of aorta atherosclerosis in resistant hypertensive patients receiving catheter-based renal artery denervation: serial volumetric computed tomography analysis (2015) (0)
- Association between prosthesis geometry and leaflet thrombosis following transcatheter aortic valve replacement (2020) (0)
- Intravascular Ultrasound Studies of Plaque Progression and Regression: Impact of Lipid-Modifying Therapies. (2018) (0)
- Mechanisms of the Vulnerable Atherosclerotic Plaque and Imaging (2020) (0)
- Rimonabant and progression of atherosclerosis in obese persons - Reply (2008) (0)
- Relationship of Cholesterol Efflux Capacity with Coronary Plaque Lipid Composition on Near Infrared Spectroscopy (2017) (0)
- Demographics and Satisfaction with Discharge Information in Cardio- and Cerebrovascular Patients (2017) (0)
- AORTIC STIFFNESS IS ASSOCIATED WITH REDUCED ADENOSINE-INDUCED HYPEREMIC MYOCARDIAL BLOOD FLOW FOLLOWING ST ELEVATION MYOCARDIAL INFARCTION (2019) (0)
- INTERNATIONAL PROSPECTIVE VALIDATION OF AN INTRACORONARY NEAR–INFRARED SPECTROSCOPY SIGNATURE OF CULPRIT LESIONS IN ACUTE STEMI (2013) (0)
- RADIOMICS-BASED PRECISION PHENOTYPING DISTINGUISHES CULPRIT AND NONCULPRIT LESIONS IN MYOCARDIAL INFARCTION AND LESIONS IN STABLE CORONARY ARTERY DISEASE (2021) (0)
- THERAPY WITH THE THYROID HORMONE RECEPTOR AGONIST EPROTIROME IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS OF THE AKKA TRIAL (2014) (0)
- Two-Year Mortality in Patients with New- Onset Atrial Fibrillation in Hospital: A Comparison Analysis with Pre-Existing Atrial Fibrillation (2019) (0)
- A beneficial role of ATP-binding cassette transporter G1-mediated cholesterol efflux capacity in regression of coronary lipid content assessed by near-infrared spectroscopy (2018) (0)
- BLOOD PRESSURE CONTROL AND ATHEROMA PROGRESSION IN DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE: INSIGHTS FROM INTRAVASCULAR ULTRASOUND (2012) (0)
- Associations of Cardiovascular Risk Factors With Cholesterol Efflux Capacity in Indigenous Australians (2018) (0)
- P2334Association between cholesterol efflux capacity and coronary plaque lipid composition on near infrared spectroscopy (2017) (0)
- FACTORS INFLUENCING THE NATURAL HISTORY OF CORONARY ATHEROMA CALCIFICATION: INSIGHTS FROM SERIAL INTRAVASCULAR ULTRASOUND (2010) (0)
- The Relationship Between Lipoprotein Particle and Attenuated Coronary Atherosclerotic Plaques in Patients Treated with Apabetalone — Insights from ASSURE Trial (2017) (0)
- 804 Clinical Predictors and Sequalae of Computed Tomography Defined Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement at Medium-Term Follow-Up (2020) (0)
- REPORTING OF CARDIOVASCULAR RISK FACTORS IN LANDMARK IMMUNE CHECKPOINT INHIBITOR TRIALS (2023) (0)
- Abstract 13616: Aorta Atheroma Burden Predicts Acute Cerebrovascular Events after Transcatheter Aortic Valve Implantation: Insights from Volumetric Multislice Computed Tomography Analysis (2014) (0)
- VARIATIONS IN ATHEROSCLEROSIS PHENOTYPE WITHIN THE CORONARY AND PERIPHERAL VASCULAR TERRITORIES: INSIGHTS FROM INTRAVASCULAR ULTRASONOGRAPHY (2012) (0)
- Relationship Between Human Coronary Endothelial Function and Lipid Rich Plaque (LRP) Burden. A Near-Infrared Spectroscopy (NIRS)/Grey Scale Intravascular Ultrasound (IVUS) Study (2016) (0)
- expert roundtable » The Role of CETP Modulation and Inhibition in the Progression of Coronary Heart Disease Moderated (2012) (0)
- The Incidence of Fatal Arrhythmia Among Patients with Early Onset Acute Coronary Syndrome and Familial Hypercholesterolaemia (2019) (0)
- Erratum: Rosuvastatin and progession of atherosclerosis (Expert Review of Cardiovascular Therapy (2008) vol.6 (7) (925-933)) (2009) (0)
- Effects of Postprandial Lipaemia on Cardiovascular Disease in Familial Hypercholesterolaemia (2019) (0)
- BREAST ARTERIAL CALCIFICATION ON SCREENING MAMMOGRAPHY PREDICTS INCIDENT CORONARY ARTERY DISEASE EVENTS (2022) (0)
- Erratum to "C-Reactive Protein Levels and Plaque Regression with Evolocumab: Insights From GLAGOV" [American Journal of Preventive Cardiology 3C (2020) 100091]. (2021) (0)
- MILANO-PILOT: will infusing HDL mimetics containing apoA-imilano continue to regress coronary atherosclerosis in the modern era of intensive statin therapy? (2017) (0)
- Computed Tomography Coronary Angiography Derived High Risk Plaques Predict Physiological Significance of Coronary Artery Stenoses as Assessed with Invasive Fractional Flow Reserve (2019) (0)
- 4. Vascular Imaging (2014) (0)
- Abstract 623: Effect of High-intensity Statin Therapy on High-density Lipoprotein (HDL) Subfractions and Regression of Coronary Atheroma: The SATURN Trial (2016) (0)
- Coronary b 2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans : novel insights from an in vivo intravascular ultrasound study (2012) (0)
- Abstract 21363: Improving Glycemic Control is Associated with A Beneficial Impact on Progression of Coronary Atherosclerosis: Insights From Intravascular Ultrasound (2010) (0)
- Combined therapies for atherosclerosis, including atherosclerotic cardiovascular disease (2017) (0)
- HDL heterogeneity and serum efflux capacity. (2015) (0)
- Abstract 1558: Changes in Markers of Systemic Inflammation Predict Progression of Coronary Atherosclerosis in Patients With Abdominal Obesity (2009) (0)
- APABETALONE (AN EPIGENETIC BET-INHIBITOR SMALL MOLECULE) AND EFFECTS ON COGNITION IN DIABETES PATIENTS WITH CARDIOVASCULAR DISEASE (2018) (0)
- 443 ANZACT, the Evolution of a Clinical Trial Network (2020) (0)
- REGRESSION OF CORONARY ATHEROSCLEROSIS IN DIABETIC PATIENTS WITH HIGH INTESITY STATIN REGIMENS: INSIGHTS FROM SATURN (2013) (0)
- Coronary Artery Disease and Pericoronary Adipose Tissue Attenuation by Computed Tomography in Familial Hypercholesterolemia (2019) (0)
- Abstract 18288: The Total-to-high Density Lipoprotein-cholesterol Ratio Associates With Coronary Atheroma Progression Rates and Reclassifies Disease Progression Across Populations With Varying Metabolic Risk (2015) (0)
- Change in High-Density Lipoprotein Cholesterol in Relation to Serial Change in Coronary Plaque Lipid Burden Assessed by Near-Infrared Spectroscopy (2017) (0)
- Monitoring pharmaceutical interventions with ivus (2006) (0)
- Comprar IVUS Made Easy (Book & DVD Set) | Steven E. Nissen | 9781841846835 | Informa Healthcare (2008) (0)
- Abstract 13340: Crp Lowering with High-Intensity Statin Therapy Associates with Regression of Coronary Atherosclerosis and Improved Clinical Outcomes: Insights from Saturn (2012) (0)
- The Relationship Between Coronary Arterial Plaque Burden and Lipid Pools: Histological Validation Using Near-Infrared Spectroscopy and Intravascular Ultrasound (2013) (0)
- Abstract 3211: Diabetes is Associated with Greater Progression of Coronary Atherosclerosis than the Metabolic Syndrome: Insights from Serial Intravascular Ultrasound Studies (2008) (0)
- P275 DOES GENDER IMPACT ON STATIN DOSE RESPONSE? RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS (2010) (0)
- Patient satisfaction with information at discharge.: Discharge information (2018) (0)
- Impact of Oxidised Very Low-Density Lipoproteins on Endothelial Cell Viability and Migration: Implications for Vascular Repair (2016) (0)
- Relationship Between Coronary Arterial Plaque Burden and Endothelium Independent Vasoreactivity: An Intravascular Ultrasound Study (2016) (0)
- Abstract 17525: Warfarin Promotes Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound (2015) (0)
- Incidence of Lipid Rich Plaque (LRP) by Near Infrared Spectroscopy (NIRS) in Near Normal Coronary Artery of Patients with Stable Presentation Versus Acute Coronary Syndrome (2016) (0)
- Reducing cardiovascular risk in patients with type 2 diabetes mellitus (2010) (0)
- HIgh-density lipoprotein cholesterol as a determinant of change in coronary plaque lipid burden assessed by near infrared spectroscopy. (2017) (0)
- ELEVATED CRP LEVELS DO NOT ADVERSELY MODULATE THE ABILITY OF EVOLOCUMAB TO REGRESS CORONARY ATHEROSCLEROSIS: INSIGHTS FROM GLAGOV (2018) (0)
- Abstract 14845: Remnant Cholesterol and Incident Atherosclerotic Cardiovascular Disease: A Pooled Cohort Primary Prevention Study (2020) (0)
- ACHIEVED LIPOPROTEIN LEVELS AND REGRESSION OF CORONARY ATHEROSCLEROSIS WITH HIGH DOSE STATIN THERAPY: INSIGHTS FROM SATURN (2012) (0)
- Artificial Intelligence-based quantification of atherosclerotic plaque and stenosis from coronary computed tomography angiography using a novel method (2022) (0)
- Abstract 948: Brain Natriuretic Peptide Levels Predict Cardiovascular Outcome in Patients with Peripheral Arterial Disease (2008) (0)
- IVUS Made Easy DVD (2008) (0)
- Abstract 558: CETP Inhibitor Increases HDL-C and Cholesterol Efflux Capacity, but Reduces Subsequent Cholesterol Esterification and Hepatic Cell Uptake (2019) (0)
- 424-P: HDL miR-181c as a Novel Biomarker for Diabetic Vascular Complications in Australian Aboriginal People (2019) (0)
- 003 TRIM2 is a Novel Inhibitor of Inflammatory-Driven Pathological Angiogenesis, but Preserves Physiological Hypoxia-Mediated Angiogenesis (2020) (0)
- Risk of early recurrence and mortality in high-risk myocardial infarction patients: A population-based linked data study (2023) (0)
- Coronary artery echo-attenuated plaques in acute coronary syndromes: a serial intravascular ultrasound imaging study (2020) (0)
- P1769Lowering the neutrophil to lymphocyte ratio by the BET inhibitor, apabetalone: potential implications for cardiovascular events in high risk patients (2017) (0)
- Statins and regression of coronary atherosclerosis. Authors' reply (2007) (0)
- Impact of statin therapy on the artery wall in the low-risk patient: implications from the METEOR study (2007) (0)
- IMPACT OF FISH OIL SUPPLEMENTATION ON ACUTE VASCULAR INFLAMMATION IN HEALTHY VOLUNTEERS (2019) (0)
- The ACTIVATE study: lessons for the future of atherosclerotic therapy (2006) (0)
- Abstract 479: Juvenile Idiopathic Arthritis Does Not Impair ABCA-1 and SR-B1-Mediated Cholesterol Efflux Capacity (2012) (0)
- Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial (2019) (0)
- Time for Intravascular Plaque Imaging to Connect the Dots From Biology to Therapeutics. (2021) (0)
- Additional Lipid Targets to Modulate Atherosclerotic Plaques beyond LDL-C Lowering (2016) (0)
- The Impact of Plaque Attenuation and Echogenicity on Clinical Outcome: Insight from Intravascular Ultrasound (2018) (0)
- Abstract 1992: Evolution of the Pattern of Atherosclerosis Assessed by Intravascular Ultrasound in Women: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2006) (0)
- The Residual Lipid-rich Coronary Atheroma behind the Implanted Newer-generation Drug-eluting Stent and Future Stent-related Event's Risks. (2022) (0)
- THE EPIGENETIC BET-INHIBITOR APABETALONE REDUCES CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES, ACUTE CORONARY SYNDROME AND AN ELEVATED ANGULO NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS SCORE - EXPLORATORY ANALYSIS OF THE BETONMACE TRIAL (2022) (0)
- DRIVERS OF PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2010) (0)
- Estimating the reduction in 10-year atherosclerotic cardiovascular disease risk with statin therapy: A VOYAGER meta-analysis (2015) (0)
- Do Cholesteryl Ester Transfer Protein Inhibitors Have a Role in the Treatment of Cardiovascular Disease? (2019) (0)
- Abstract 1460: Clinical Predictors of Atherosclerosis Progression in Patients With Very Low Levels of LDL Cholesterol (2009) (0)
- Effect of High Intensity Statin Therapy on Intravascular Ultrasound Features of Coronary Plaque Instability (2016) (0)
- Abstract 12775: The Impact of Spotty Calcification on Microstructures Within Thin-cap Fibroatheromas: Frequency Domain Optical Coherence Tomography Analysis (2013) (0)
- SP436DESIGN FEATURES OF THE BETONMACE CHRONIC KIDNEY DISEASE SUB-STUDY; EFFECTS OF THE SELECTIVE BET-INHIBITOR APABETALONE ON KIDNEY FUNCTION AND MACE IN POST-ACS PATIENTS WITH ESTIMATED GLOMERULAR FILTRATION RATE BELOW 60 AND DIABETES (2018) (0)
- THE EFFECT OF HIGH–INTENSITY STATIN THERAPY ON CHANGES IN ATHEROMA COMPOSITION: INSIGHTS FROM SATURN (2013) (0)
- High-Dose Omega-3 Fatty Acids in Cardiovascular Prevention: Finally Living Up to Their Potential? (2019) (0)
- Abstract: 1495 ATHEROSCLEROTIC PROGRESSION AND REMODELING IN ARTERIES WITH MINIMAL ANGIOGRAPHIC DISEASE (2009) (0)
- 012 Clinical Predictors and Sequalae of Computed Tomography (CT) Defined Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR) at Medium-Term Follow-Up (2020) (0)
- Abstract 10446: Accelerated Progression of Coronary Atherosclerosis in Hyporesponders to Statin Therapy (2011) (0)
- Intensive lipid lowering in the cardiovascular patient: Who, how low, and for how long? (2007) (0)
- CX3CR1 Identifies Adventitial Macrophage Progenitor Cells (AMPCs), a Local Source of Self-Renewing Macrophages in Postnatal Arteries (2016) (0)
- Abstract 660: Elevated Calcium Drives Inflammatory-Driven Angiogenesis (2018) (0)
- Abstract 13095: Regression of Left Main Coronary Arterial Atherosclerosis: Implications for Major Adverse Cardiovascular Events (2011) (0)
- Abstract 14396: TRIM2 and CREBRF Are Novel Regulators of Angiogenic Functions in Human Coronary Artery Endothelial Cells (2019) (0)
- THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL (2020) (0)
- CETP Inhibitor Evacetrapib Reduces LDL-C and Raises HDL-C Levels (2011) (0)
- P4608BET-inhibition with Apabetalone in Post-ACS Patients with Diabetes: Design and Baseline Characteristics of the BETonMACE trial (2019) (0)
- Abstract 5512: Plasma Myeloperoxidase is Independent Predictor of Incident Major Adverse Clinical Events in Stable Patients Undergoing Elective Coronary Angiography (2008) (0)
- Abstract 3726: Beta-Blockers and Progression of Coronary Atherosclerosis:A Meta-Analysis from Four Intravascular Ultrasound Trials (2006) (0)
- Abstract 10905: Breast Arterial Calcification as a Novel Predictor of Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis (2021) (0)
- Comprar IVUS Made Easy DVD | Steven E. Nissen | 9781841846507 | Informa Healthcare (2008) (0)
- Abstract 13108: Intensive Multi-target Lipid Lowering and Progression of Coronary Atherosclerosis (2010) (0)
- MEASURES OF HIGH-DENSITY LIPOPROTEIN QUANTITY AND QUALITY PREDICT CARDIOVASCULAR OUTCOME AT ALL LEVELS OF MYELOPEROXIDASE (2010) (0)
- Abstract 701: Pharmaceutical Inhibition of CETP Perturbs HDL Subspecies Profile, Increasing HDL That Contains ApoC3 (2019) (0)
- In vivo evaluation of human coronary structure-function predicts subsequent progression of coronary atherosclerotic plaques: a near infrared spectroscopy study (2017) (0)
- Translating evidence from clinical trials of omega-3 fatty acids to clinical practice. (2020) (0)
- Association Between Prosthesis Geometry And Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement On Assessment With 320-slice Scanner Ct. [for Consideration Of Soar Award] (2020) (0)
- PLAQUE CHARACTERIZATION INFORMS THE RISK OF PERIPROCEDURAL MYOCARDIAL INFARCTION DURING PCI: THE COLOR REGISTRY (2016) (0)
- P4473Baseline insulin levels are associated with need for revascularization among diabetic patients with high risk vascular disease: insights from the ACCELERATE trial (2018) (0)
- Abstract: P964 IMPACT OF STATIN DOSE ON LIPID LEVELS IN PATIENTS WITH ATHEROSCLEROTIC DISEASE: RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIS (2009) (0)
- 176 ANTI-INFLAMMATORY EFFECTS OF A NOVEL INDUCER OF APOLIPOPROTEIN A-I SYNTHESIS: INSIGHTS FROM THE ASSERT STUDY (2011) (0)
- TCT-24 Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment Of Coronary Plaque Burden and Lipid Pools: Validation With Histology (2012) (0)
- Label-free assessment of endothelial cell metabolic state using autofluorescent microscopy (2016) (0)
- Abstract 19510: Regression of Coronary Atherosclerosis With the PCSK9 Inhibitor Evolocumab in Patients With Coronary Artery Disease and Diabetes (2017) (0)
- Abstract 11279: The Impact of Intensive LDL-C Lowering Therapy on Vulnerable Plaque Microstructures: Frequency Domain Optical Coherence Tomography Analysis (2013) (0)
- Impact of Remnant Lipoprotein Cholesterol on Coronary Plaque Burden Assessed by Computed Tomography Coronary Angiography (2018) (0)
- Pathophysiology of Atherosclerosis (2020) (0)
- TCT-23 Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction (2012) (0)
- Examining controversies and new frontiers in lipid management (2014) (0)
- DOES CORONARY CALCIUM SCREENING INFLUENCE ANXIETY, DEPRESSION OR QUALITY OF LIFE IN ASYMPTOMATIC PATIENTS AT INTERMEDIATE RISK? (2022) (0)
- 037 Eukaryotic Elongation Factor 2 Kinase (eEF2k) Regulates Foam Cell Formation and Atherosclerosis by Promoting Translation and Glycosylation of CD36 Scavenger Receptor Expression in Macrophages (2020) (0)
- Protective lipid-lowering genetic variants in healthy older individuals without coronary heart disease (2021) (0)
- Abstract 16218: Long-Term Anti-Atherosclerotic Effects of Maximally Intensive Statin Therapy Following Acute Coronary Syndrome: Insights From SATURN (2013) (0)
- Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes (2022) (0)
- Using Imaging to Identify the High-Risk Diabetic Patient: Are We Any Closer? (2017) (0)
- 006 Left Atrial Ejection Fraction Predicts Future need for Surgery in Asymptomatic Patients With Rheumatic Mitral Valve Disease (2020) (0)
- Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case C ONTROVERSIES I N C ARDIOVASCUlAR M EDICINE (2015) (0)
- CLINICAL PREDICTORS OF CULPRIT LESION LIPID QUANTIFIED BY NEAR INFRARED SPECTROSCOPY: INSIGHTS FROM THE COLOR REGISTRY (2018) (0)
- Pro-Calcific Environment Impairs Ischaemia-Driven Angiogenesis (2022) (0)
- P1104The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial (2017) (0)
- The impact of anti-atherosclerotic strategies on subclinical atherosclerosis (2005) (0)
- BENEFICIAL EFFECTS OF RAISING HIGH-DENSITY LIPOPROTEIN CHOLESTEROL DEPENDS ON LEVELS OF ATHEROGENIC LIPIDS: IMPLICATIONS FOR DISEASE PROGRESSION AND CLINICAL EVENTS (2014) (0)
- HDL PARTICLE CONCENTRATION IS NOT ASSOCIATED WITH RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS FOLLOWING ACUTE CORONARY SYNDROMES (2018) (0)
- Phenotypic Features of Coronary Atheroma in Diabetic and Nondiabetic Patients With Low-Density Lipoprotein Cholesterol <55 mg/dL. (2022) (0)
- Fluid-structure analysis of an atherosclerotic coronary artery (2018) (0)
- TCT CONNECT-386 Diabetes Mellitus Is Associated With Increased Risk of Early Stent-Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR) (2020) (0)
- Monitoring the Progression and Regression of Coronary Atherosclerosis with Intravascular Ultrasound (2014) (0)
- Predicting the reduction in risk of cardiovascular events with high-intensity statin treatment: A voyager analysis (2015) (0)
- Good Heart: Aboriginal Women's Understanding of Risk and Protective Factors (2019) (0)
- Computed tomography coronary angiography can accurately quantify coronary luminal area and plaque volume compared to invasive intravascular ultrasound (2015) (0)
- Combined Exposure to both Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure with Lifetime Risk of Cardiovascular Disease. JAMA (2019) (0)
- Response to Letter Regarding Article, “Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarct” (2008) (0)
- Abstract 14012: Alkaline Phosphatase: An Alternative Inflammatory Risk Marker After Coronary Syndrome (2017) (0)
- Angiotensin II Regulates the Clonogenicity, Self-Renewal and Gene Expression of Murine Adventitial Macrophage Progenitor Cells (AMPCs) (2017) (0)
- TO001EFFECTS OF THE BET-INHIBITOR APABETALONE ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ACUTE CORONARY SYNDROME, ACCORDING TO PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE. A BETONMACE TRIAL REPORT (2020) (0)
- A novel non-invasive pulmonary vasoreactivity protocol utilising cardiac magnetic resonance imaging in patients with known or suspected pulmonary arterial hypertension (PAH) (2015) (0)
- Scratching the surface of atherosclerosis: Distinguishing phenotypes of plaque erosion. (2022) (0)
- Epanova Lowers Apolipoprotein C-III and Increases LDL-Particle Size in Statin-Treated Patients With Mild Hypertriglyceridemia (2013) (0)
- Plaque Characterisation Informs the Risk of Peri-MI During PCI: The COLOR Registry (2016) (0)
- 871a Prosthesis Geometrical Predictors of CT Defined Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement (2020) (0)
- ASSOCIATION BETWEEN HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE AND SURVIVAL IN DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE ALECARDIO TRIAL (2017) (0)
- Effects of CPAP treatment on cardiac structure and function in individuals with obstructive sleep apnea and cardiovascular disease: a prospective 6-month randomised control trial (2020) (0)
- ATHEROGENIC LIPOPROTEIN VARIABILITY CORRELATES WITH CORONARY ATHEROMA PROGRESSION: INSIGHTS FROM SERIAL INTRAVASCULAR ULTRASONOGRAPHY (2017) (0)
- The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis (2018) (0)
- Vascular calcification in response to pharmacological interventions (2019) (0)
- Abstract 4149: Regression of Coronary Atherosclerosis Following Intensive Risk Factor Modification in Patients With the Metabolic Syndrome (2006) (0)
- Atherosclerotic Plaque Imaging for Evaluation of HDL Targeting Therapy (2014) (0)
- Effect of individual high-intensity statin agents on optical coherence tomography derived measures of plaque stability (2015) (0)
- 705 Rates of Surgical Intervention in Aboriginal Patients With Significant Rheumatic Heart Disease (2020) (0)
- Abstract 15172: Quantitative Changes in High-Density Lipoprotein Underlie Impaired SR-B1 Mediated Efflux in Obese Individuals (2011) (0)
- Cardiovascular Outcomes in Patients with Abnormal Global Left Ventricular Contractile Response on Exercise Stress Echocardiogram (2019) (0)
- ARTERIAL WALL REMODELING IN ASSOCIATION WITH ABDOMINAL OBESITY, ADIPOCYTOKINES AND PROGRESSION OF CORONARY ATHEROSCLEROSIS: INSIGHTS FROM THE STRADIVARIUS STUDY (2010) (0)
- Gender related differences of serial change in coronary plaque composition. (2017) (0)
- The association between PCSK9 inhibitor use and sepsis - A systematic review and meta-analysis of 20 double-blind, randomized, placebo-controlled trials. (2023) (0)
- Benefits of Inducing ApoA1 Synthesis Still Unclear: Results from ASSERT (2010) (0)
- Transient Triglyceridaemia Reduces the Anti-inflammatory Properties of High-density Lipoprotein (2007) (0)
- Therapy with the thyroid hormone receptor agonist eprotirome in patients with familial hypercholesterolemia: a randomised, double blind, placebo-controlled study (2014) (0)
- INCREASED LIPID-RICH PLAQUE BUT NOT GREATER PLAQUE BURDEN IN MYOCARDIAL INFARCTION LESIONS: THE COLOR REGISTRY (2016) (0)
- Abstract: P1386 LOWERING OF HBAIC IS ASSOCIATED WITH LESS PROGRESSION OF CORONARY ATHEROSCLEROSIS (2009) (0)
- P630Comparison of plaque microstructures between two high-intensity statin therapies: rosuvastatin versus atorvastatin (2017) (0)
- Does Body Adiposity Better Predict Obesity-Associated Cardiometabolic Risk Than Body Mass Index? (0)
- Shining the Light on Calcium in the Catheterization Lab. (2016) (0)
- CAN A SIMPLE ECHO DOPPLER VTI BASED FLOW COMPARISON BETWEEN THE LVOT AND RVOT ASSIST IN GRADING AORTIC REGURGITATION? (2022) (0)
- Will apoA-I-based therapies step up to cure coronary artery disease? (2011) (0)
- Angiographic functional scoring of coronary artery disease predicts mortality in patients with severe aortic stenosis undergoing TAVR. (2020) (0)
- Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes (2020) (0)
- Abstract 4106: Effect of Obesity on Progression of Coronary Atherosclerosis: Observations from Four Intravascular Ultrasound Trials (2006) (0)
- Abstract 169: Lipoproteins and their Modified Forms Regulate Smooth Muscle Cell Calcification (2018) (0)
- Incidence of Early Cardiovascular Events Following Acute Coronary Syndromes in Men and Women: Insights From VISTA-16 (2016) (0)
- Current and Emerging Therapies for Atherosclerosis (2020) (0)
- CHAPTER 34 – Invasive Imaging Modalities and Atherosclerosis: The Role of Intravascular Ultrasound (2009) (0)
- OPTICAL COHERENCE TOMOGRAPHY DERIVED MEASURES OF PLAQUE VULNERABILITY IN OBESE PATIENTS WITH CORONARY ARTERY DISEASE (2014) (0)
- Abstract 2886: Angiotesin-Converting Enzyme Inhibitors Attenuate Age-related Progression of Cardiac Allograft Vasculopathy - A Serial Volumetric Intravascular Ultrasound Study (2007) (0)
- L4 BASELINE CHARACTERISTICS OF PATIENTS IN THE SATURN STUDY, A COMPARISON OF ROSUVASTATIN VERSUS ATORVASTATIN ON CORONARY ATHEROSCLEROTIC DISEASE BURDEN (2010) (0)
- Coronary artery disease: what is the role of inflammation? (2014) (0)
- TCT-245 Impact of Statin Therapy on Plaque Microstructures on Optical Coherence Tomography (2012) (0)
- Greater circulating concentrations of large HDL particles associate with more favorable HDL functionality in young adults. (2017) (0)
- Aorta Atheroma Burden Predicts Acute Kidney Injury after Transcatheter Aortic Valve Implantation: Volumetric Computed Tomography Analysis (2016) (0)
- Epicardial Adipose Tissue in Indigenous and Non-Indigenous Australians: Implications for Cardiometabolic Diseases (2019) (0)
- Cerebral Blood Flow, Endothelial Function In Patients With Coronary Artery Disease And Arterial Hypertension Receiving Ivabradine In Combination With Perindopril (2014) (0)
- Intracoronary IVUS for Evaluation of Atherosclerosis Progression (2012) (0)
- Lipid lowering in patients with kidney disease - is it really that hard? (2015) (0)
- THE DEGREE OF GLYCEMIC CONTROL IS ASSOCIATED WITH EXTENSIVE SUBCLINICAL ATHEROSCLEROSIS AND IMPAIRED SR-BI MEDIATED EFFLUX IN OBESE INDIVIDUALS (2012) (0)
- Abstract 3133: Prognostic Utility of Detectable Plasma Cardiac Troponin I in Stable Patients Undergoing Elective Coronary Angiography Without Myocardial Infarction (2008) (0)
- Label-Free Oxidative Imaging of Ageing Endothelial Cells (2016) (0)
- Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial (2015) (0)
- Abstract 13297: Temporal Changes in Management of Heart Transplant Recipients and Impact on Coronary Allograft Vasculopathy (2012) (0)
- Abstract 3269: Does The Metabolic Syndrome Promote Progression of Coronary Atherosclerosis Beyond The Impact of its Component Risk Factors? Observations From Intravascular Ultrasound (2008) (0)
- Abstract 14775: Differential Responses of Atheroma Progression to Blood Pressure Lowering in Patients with and without Diabetes (2014) (0)
- LEVELS OF NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL DO NOT NEGATIVELY IMPACT THE ABILITY OF THE PCSK9 INHIBITOR, EVOLOCUMAB, TO PROMOTE REGRESSION OF CORONARY ATHEROSCLEROSIS (2018) (0)
- Spotty Calcification Associates with Coronary Plaque Microstructures In Vivo: Insights From Fourier-Domain Optical Coherence Tomography Analysis (2013) (0)
- Abstract 1021: High Cholesteryl Ester Transfer Protein Mass Predicts Accelerated Progression of Coronary Atherosclerosis in Abdominally Obese Patients (2009) (0)
- Comprar Cardiovascular Imaging For Clinical Practice | Stephen Nicholls | 9780763756222 | Jones & Bartlett Publishers (2010) (0)
- Abstract 14307: Reduction in the Risk of Major Adverse Cardiovascular Events With Apabetalone, a Bet Protein Inhibitor, in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes According to Insulin Treatment: Analysis of the Betonmace Trial (2020) (0)
- Co-registration of Intravascular Ultrasound and Angiography (2016) (0)
- Abstract: P965 STATIN DOSE EFFECTS ON LIPID LEVELS IN PATIENTS WITH DIABETES MELLITUS: OBSERVATIONS FROM THE VOYAGER INDIVIDUAL PATIENT DATA (IPD) META-ANALYSIS (2009) (0)
- ANGIOGRAPHIC PREDICTORS OF LIPID RICH PLAQUE DETECTED BY NEAR-INFRARED SPECTROSCOPY: THE COLOR REGISTRY (2018) (0)
- REDUCTION IN TRIGLYCERIDE LEVELS ASSOCIATE WITH RAPID REGRESSION OF CORONARY ATHEROSCLEROSIS AFTER AN ACS (2018) (0)
- The Role of CETP Modulation and Inhibition in the Progression of Coronary Heart Disease (2020) (0)
- Translation and Impact of Funded Australian Cardiovascular Research: A Review With Perspective. (2021) (0)
- ATRIAL FIBRILLATION IS NOT ASSOCIATED WITH INCREASED PROGRESSION OF CORONARY ATHEROSCLEROSIS: INSIGHTS FROM INTRAVASCULAR ULTRASOUND ATHEROSCLEROSIS TRIALS (2010) (0)
- Favorable cognitive effects of the BET protein inhibitor apabetalone in patients 70 and older (2021) (0)
- Abstract 15013: The Regulation of miRNAs in rHDL-Induced Rescue of Diabetes-Impaired Angiogenesis (2017) (0)
- Tackling Cardiovascular Risk in Type 2 Diabetes: Does Baseline Glucose Control Matter? (2018) (0)
- Secretory phospholipase: a potential target for cardiovascular therapies (2013) (0)
- Abstract 1494: Paraoxonase 1 Activity Predicts Prevalence, Severity and Progression of Coronary Artery Disease at All Levels of High-Density Lipoprotein Cholesterol (2006) (0)
- The relationship between segmental wall shear stress and NIRS-derived lipid core plaque. (2017) (0)
- Associations of Cardiovascular Risk Factors With Antioxidative Capacity of High-Density Lipoproteins in Indigenous Australians (2018) (0)
- ALEGLITAZAR LOWERS THE TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (2012) (0)
- The Effect of a High Fat Diet and Weight Gain on Reverse Cholesterol Transport in Rabbits (2016) (0)
- IMPACT OF STATIN THERAPY ON PLAQUE MICROSTRUCTURES ON OPTICAL COHERENCE TOMOGRAPHY (2016) (0)
- Statin Therapy Alters the Relationship Between Apolipoprotein B and Both LDL-C and Non-HDL-C in High-Risk Patients: Effect of Race/Ethnic Background † (2012) (0)
- GW24-e3085 The dual PPAR alpha/gamma agonist aleglitazar has a beneficial effect on atherogenic dyslipidemia in patients with type 2 diabetes (2013) (0)
- PREVALENCE OF CAROTID WALL TRIPLE LINE PATTERN AND ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS AMONG INDIVIDUALS UNDERGOING CAROTID INTIMA-MEDIA THICKNESS TESTING (2012) (0)
- Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study (2022) (0)
- Predictors of Anticoagulation Use for the Prevention of Stroke in Indigenous and Non-Indigenous Australians with Atrial Fibrillation (2017) (0)
- ORION-3: delivering lipid lowering treatment for longer. (2023) (0)
- PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectives. (2023) (0)
- Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation (2023) (0)
- Lipoprotein(a): cardiovascular risk and emerging therapies (2023) (0)
- Getting to the heart of the matter: a research partnership with Aboriginal women in South and Central Australia (2022) (0)
- Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. (2023) (0)
- Should we continue to subsidise therapeutics with uncertain efficacy? Health economic implications for icosapent ethyl. (2022) (0)
- Atherogenic index of plasma is associated with epicardial adipose tissue volume assessed on coronary computed tomography angiography (2022) (0)
- Change Over 70 Years of Cardiac Society of Australia and New Zealand. (2022) (0)
- Strengthening cardiovascular trials across Australia and New Zealand-the Alliance for Cardiovascular Trials (ANZACT) Network. (2021) (0)
- Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial) (2023) (0)
- Blood pressure surveillance in cancer patients treated with immune checkpoint inhibitors. (2023) (0)
- CETP Inhibitors: Should We Continue to Pursue This Pathway? (2022) (0)
- A systematic review on assessment and management of preventive cardiovascular care in primary health for Aboriginal and Torres Strait Islander women and men. (2022) (0)
- PCSK9 Inhibitors and Coronary Atherosclerosis: Insights From Recent Intravascular Imaging Clinical Trials (2023) (0)
- A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis. (2023) (0)
- Providing guideline-recommended preventive cardiovascular care to Aboriginal and Torres Strait Islander women: exploring gender differences with a medical record review in primary health care. (2022) (0)
- Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol (2022) (0)
- Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region (2021) (0)
- Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic review. (2023) (0)
- P6213The influence of working-age on attendance to cardiac rehabilitation: a gender comparison (2019) (0)
- HDL Cholesterol and Cardiovascular Risk: Teasing the Answer From the Complexity. (2023) (0)
- Association Between Spontaneous Internal Carotid Artery Dissection and Perivascular Adipose Tissue Attenuation on Computed Tomography Angiography. (2023) (0)
- Prognostic Value of Exercise Capacity in Kidney Transplant Candidates (2022) (0)
- Contemporary Chest Pain Evaluation: The Australian Case for Cardiac CT. (2023) (0)
- Vasculogenic properties of adventitial Sca-1+CD45+ progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis (2019) (0)
- A demonstration of multiplex biosensing using whispering gallery mode microspheres positioned onto a microstructured optical fiber tip (2014) (0)
- Using whispering gallery mode micro lasers for biosensing within undiluted serum (2016) (0)
- 3D micro-printing of miniaturized fiber-optic probes capable of multi-modal imaging and beam tailoring (2023) (0)
- Optimization of whispering gallery mode sensor design for applications in biosensing (2015) (0)
- Eukaryotic Elongation Factor 2 Kinase (eEF2k) Regulates Cholesterol Uptake by Macrophages via CD36 Scavenger Receptor Expression (2019) (0)
- A Novel Ruthenium-based Molecular Sensor to Detect Endothelial Nitric Oxide (2019) (0)
- Postnatal Mouse Aorta Contains Yolk Sac-Derived Haemangioblasts with Myeloid and Endothelial Plasticity and Vasculogenic Capacity (2019) (0)
This paper list is powered by the following services:
Other Resources About Stephen Nicholls
What Schools Are Affiliated With Stephen Nicholls?
Stephen Nicholls is affiliated with the following schools:
